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Abstract 
 
Psyllium has been shown to exert beneficial effects on intestinal health and 
function in several non-ruminant species.  The effects of psyllium inclusion in milk 
replacers for neonatal dairy calves  have been minimally researched. The purpose of my 
research was to determine the impact of psyllium inclusion in milk replacer on feed 
intake, water intake, growth, illness, digesta viscosity, rate of passage, nutrient 
digestibilities, blood components, VFA concentrations and microbial populations 
throughout the gastrointestinal tract, size and scale of gastrointestinal tissues, ion 
transport measures, and histomorphological development in the gastrointestinal tract in 
neonatal dairy calves.   
Male Holstein calves, less than 36 h of age, were purchased for this trial.  Calves 
were blocked by pairs and randomly assigned within pair to one of two dietary 
treatments. Treatments consisted of milk replacers (reconstituted to 12.5% DM and fed at 
a rate of 12% of BW) formulated to contain 22% protein and 20% fat either with (PSY) 
or without (CON)  a 1.1% inclusion of psyllium.  Pairs of calves were harvested at wk 1, 
2, 3, and 4 for analysis.  
Feed intake (DM, protein, and metabolizable energy), water intake, growth, and 
illness did not differ between treatments. Digesta viscosity was increased in the abomasal 
and colon digesta for the PSY treatment. In addition, DM content of digesta from the 
proximal colon, distal colon, and feces was decreased for the PSY treatment. Apparent 
digestibility of DM was greater for the CON treatment. The predominant effect of 
psyllium inclusion in the milk replacer on VFA concentrations was in the lower 
gastrointestinal tract as indicated by the higher total VFA concentrations in the jejunum, 
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proximal colon, and distal colon. Greater lower gut fermentation is logical because 
psyllium is a fiber that can be fermented by intestinal bacteria. Effects of inclusion of 
psyllium on bacterial counts were minimal.  
Size and scale of the gastrointestinal tract were impacted by psyllium 
predominantly in the lower gastrointestinal tract. Calves fed PSY had heavier 
duodenums, more duodenal tissue per kilogram BW, increased duodenal wet weight, 
increased jejunal mass per unit of BW, denser jejunal tissue, and greater jejunal tissue 
density per unit of BW. Length of the jejunum per unit of calf BW was increased for the 
CON calves. In the ileum, the PSY calves had denser tissue. Colon wet weight, as well as 
dense colon tissue per unit of calf BW was increased for the PSY calves. The increase in 
size and scale of the gastrointestinal tract could be of benefit to the neonatal dairy calf 
from a standpoint of potentially greater absorptive capacities of the tissue and greater 
tissue resistance to disease intrusion into the bloodstream. The inclusion of a fermentable 
fiber could also potentially “set-up” the gastrointestinal tract to allow more rapid growth 
once calf starter ingestion begins. 
In isolated segments of gastrointestinal tissues, inclusion of psyllium in the diet 
significantly affected the change in short circuit current induced by addition of  10 mM 
glucose. Glucose transport was greater in rumen, ileum, and colon from CON calves 
compared with calves fed PSY . These data could potentially indicate that psyllium 
inclusion slowed the rate of glucose absorption in the rumen, ileum, and colon. 
Psyllium inclusion in milk replacer resulted in physiological changes consistent 
with improved performance and health.  The effects of psyllium inclusion on growth and 
health should be determined in large numbers of calves under field conditions. 
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Chapter 1 
Literature Review 
 
Rumen Development in the Neonatal Dairy Calf 
 The dairy calf is born a unique and complex animal.  At birth, the rumen, 
reticulum, and omasum of the ruminant stomach are present; however, these three 
compartments are underdeveloped.  This fact, in conjunction with the esophageal groove 
and developmental state of abomasal and intestinal enzymes, compels the neonatal dairy 
calf to function as a monogastric animal (Heinrichs, 2005). The abomasum is considered 
the "true stomach" of the calf; this is attributed to the ability of the abomasum to carry 
out gastric digestion of proteins similar to the stomach of non-ruminants (Davis and 
Drackley, 1998).   
 Ingestion of dry feeds and the microbial end-products (short-chain fatty acids or 
volatile fatty acids; VFA) produced as a result of fermentation of the dietary carbohydrate 
and protein fractions have been shown to stimulate rumen epithelial development (Davis 
and Drackley, 1998).  Rumen development can be attributed to the presence and 
absorption of VFA.  Each VFA is unique in its metabolism, and the effects of each VFA 
on rumen development are also unique.  Butyrate is the VFA most responsible for 
stimulation of rumen epithelial development, with propionate being the second most 
stimulatory (Heinrichs, 2005). 
 In newborn calves (0-3 days), the papillae of the rumen are partially developed.  
However, if the calf receives a diet of only milk or milk replacer, the papillae will show 
regressive changes, both in length and shape (Tamate et al., 1962).  This regression of 
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growth is theorized to result from the lack of VFA reaching the rumen from the milk diet, 
because of esophageal groove closure.  Rumen development present in newborn calves 
can be attributed to VFA in the maternal blood, which then supplied the fetal rumen 
tissue with VFA for papillae growth and development (Tamate et al., 1962).  
 The esophageal or reticular groove is a unique muscular fold whose closure 
allows liquid feeds to bypass the reticulo-rumen and be shunted into the abomasum of the 
calf (Warner et al., 1956). When solid feeds are consumed, they are directed into the 
reticulo-rumen (Church, 1988).  Therefore, milk or milk replacer consumed by the calf 
has limited ability to stimulate rumen development (Warner et al., 1956).  When calves 
consume only milk or milk replacer, minimal rumen epithelial metabolic activity and 
VFA absorption occur, and this is not affected by increasing age.  On the contrary, the 
size of the rumen of calves fed milk or milk replacer has been shown to increase 
proportionally with body size (Vazquez-Anon et al., 1993).   
 The impact of VFA to stimulate development of the structure and absorptive 
ability of the ruminal mucosa is through stimulation of metabolism in the ruminal mucosa 
(Sutton et al., 1963).  In neonatal sheep, infusion of physiological concentrations of VFA 
may stimulate rumen morphological and metabolic development (Lane and Jesse, 1997). 
 
Dietary Fiber 
 Polysaccharides, one of the three classified groups of carbohydrates, are polymers 
of simple sugars (monosaccharides) and derivatives thereof (Garrett and Grisham, 1999).  
The physical properties of polysaccharides are dominated by the conformation of the 
individual chains and the way in which they interact with one another (Morris, 2001).   
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 Dietary fiber is a complex mixture of polysaccharides with different functions and 
activities during passage through the gastrointestinal tract.  Many of the functions and 
activities of fiber are dependent upon its physicochemical properties.  These properties 
include solubility, viscosity, water-holding capacity, and adsorption of small molecules 
and ions (Oakenfull, 2001).   
The current definition of dietary fiber (plant material that resists digestion by the 
enzymes of the human alimentary tract; Blackwood et al., 2000) includes a number of 
non-starch polysaccharides (NSP) composed of gums and mucilages from a variety of 
seeds and fruits, as well as the cellulose and hemicellulosic polysaccharides and lignin 
(Blackwood et al., 2000).   
 The predominant role of dietary fiber in the stomach and small intestine is to limit 
the rate of release of nutrients. This may occur by physical trapping of sugars, lipids, and 
proteins within solid particles or hydrated networks. Another mechanism is by increasing 
the viscosity of the digesta, therefore reducing the rate of nutrient transport to the 
epithelium. Both of these mechanisms focus on physical properties of fiber, as opposed to 
its chemical composition (Morris, 2001).   By definition, fiber is not broken down by 
enzymes of the gastrointestinal tract. However, virtually all fiber fractions are fermented 
to some extent by the microorganisms in the cecum and colon.  Fermentation depends 
upon accessibility of the polysaccharide molecules to the microorganisms, which in turn 
depends upon chemical structure and physical properties, particularly solubility 
(Oakenfull, 2001).  The physiological properties of dietary carbohydrates are dependent 
on site, rate, and extent of absorption or fermentation in the intestine. In humans, 
consumption of dietary fiber has been found to increase stool weight, alter gut transit 
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time, alter activity of colonic microflora, modify absorption of fats, sugars, minerals, and 
bile acids, influence appetite, and absorb toxins. The extent to which specific dietary 
fibers exert these physiological effects is dependent on a complex mixture of structural, 
chemical, and physical properties (Blackwood et al. 2000).   
 In the field of ruminant nutrition, the most common measures of fiber are crude 
fiber (CF), acid detergent fiber (ADF), and neutral detergent fiber (NDF).  None of these 
three measures are chemically uniform.  Crude fiber is considered obsolete and typically 
is not measured except for feed regulatory purposes.  Neutral detergent fiber is 
predominantly a measure of the structural or cell wall components of plant cells, 
including cellulose, hemicellulose, and lignin.  Acid detergent fiber is a measure of 
cellulose and lignin.  Non-structural carbohydrates (NSC) are not recovered in the NDF 
fraction and comprise sugars, starches, organic acids, and other carbohydrates.  NSC can 
be classified as water soluble, although some larger polysaccharides are insoluble 
(National Research Council, 2001).     
 
Psyllium 
 Psyllium (Plantago ovata Forsskaol) is a herbaceous low-growing annual plant 
native to India and Iran, and is also referred to as Ispaghul (Blumenthal et al., 2000).  The 
seed husks of this plant, Plantago ovata, are commonly referred to as ispaghula husks 
(Leng-Peschlow, 1991) or psyllium (Washington et al., 1998).  
 Psyllium seed husk is composed of mucilaginous polysaccharides, with a highly 
branched acidic arabinoxylan containing a xylan backbone (Washington et al., 1998; 
Blumenthal et al., 2000).  Arabinoxylans are natural polysaccharides with highly 
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branched structures (Edwards et al., 2003).  Marlett and Fischer (2003) reported that 
psyllium seed husk is composed of 902 mg/g carbohydrate, 35 mg/g crude protein, and 
34 mg/g ash.   
 Psyllium husk is a gel-forming, water-soluble fiber (McCall et al., 1992a; Sierra 
et al., 2002).  Psyllium possesses limited ion-exchanging capacity (McCall et al., 1992a).   
Psyllium interacts with water to form three fractions: a soluble fraction, a gel fraction, 
and the matrix fraction (Al-Assaf et al., 2003).  Marlett and Fischer (2002) have 
identified these same three fractions, and have identified them as Fraction A, Fraction B, 
and Fraction C.  Fraction B is a physiologically active gel-forming component unique to 
psyllium seed husk, with a highly branched arabinoxylan polysaccharide (Fischer et al., 
2004), a xylose backbone, and arabinose and xylose side chains (Marlett and Fischer, 
2003).  
 Arabinoxylans are an important fraction of non-starch polysaccharides (NSP) in 
dietary fiber that have been linked to increased fecal bulking as a result of the high water 
holding capacity and low degradability (Edwards et al., 2003).  Psyllium husks contain a 
high concentration of mucilage polysaccharides that gel over a wide range of 
concentrations (Washington et al., 1998).  The psyllium husk interacts with water to yield 
a visco-elastic system that is preserved throughout its transit in the colon.  The solid 
matrix of the psyllium husk interacts with water to yield a gel fraction and a completely 
soluble fraction capable of rapid fermentation to short-chain fatty acids (i.e., VFA).  
These physical and chemical states can initiate a series of physical and physiological 
processes during transit through the colon (Al-Assaf et al., 2003).  
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 Current applications of psyllium in the United States include uses in human over-
the-counter dietary supplements for increased fiber, cholesterol reduction, and laxative 
activity.  The Food & Drug Administration in 1998 amended its soluble fiber health 
claim regulation to include blonde psyllium husk as a source (Blumenthal et al., 2000).   
 
Viscosity 
 In order to understand the viscous nature of psyllium and the resultant effects it is 
imperative first to define viscosity.  Viscosity is the ratio of shear stress to shear rate, 
where shear stress is the resistance to rotation and shear rate is the amount of strain 
applied per second.  Since stress is defined as units force per unit area, it has units of 
pressure, or pascals (Pa).  Because strain is a dimension-less ratio, shear rate has units of 
reciprocal time (s
-1
). The resultant measurement of viscosity is Pa·s.  One Pa·s is 
equivalent to 1 centipoise (cP).  More simply, viscosity is the tendency of a liquid to 
reduce flow (Morris, 2001).   
 Viscosity is caused by physical interactions between polysaccharide molecules in 
a solution, and most water-soluble fibers form viscous solutions (Oakenfull, 2001).  
Arabinoxylans (such as psyllium) exhibit a high viscosity in aqueous solution due to their 
extended conformity (Blackwood et al., 2000). 
 The viscosity of solutions of disordered coils is strongly dependent upon 
concentration. In dilute solutions, the individual coils are free to move independently, and 
generate viscosity by tumbling and interfering with the flow of the solvent. Dilute 
solutions tend to exhibit Newtonian behavior, where the resistance to flow is almost 
directly proportional to the shear rate, and viscosity will remain virtually constant.  As the 
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polymer concentration is raised, a point is reached at which the polymers begin to touch, 
and as concentration rises, the polymers overlap and interpenetrate one another. The 
transition from a solution of individual coils to an entangled network of overlapping 
chains is accompanied by a sharp increase in the concentration dependence of viscosity, 
and by the onset of non-Newtonian behavior. At higher shear rates, extent of random coil 
overlap decreases, and viscosity falls. This is known as shear thinning (Morris, 2001), 
which psyllium exhibits (Dikeman et al., 2006). 
 Gastric emptying is known to be powerfully influenced by meal viscosity, with 
more viscous meals allowing less deep, and therefore less effective, antral contractions 
associated with delayed gastric emptying (Washington et al., 1998). As fiber meal 
viscosity increases, meal emptying time is prolonged in dogs (Russell and Bass, 1985). 
Including psyllium at 1% of the diet resulted in digesta that exhibited a near Newtonian 
flow with a low viscosity compared to a meal containing 3% psyllium meal (Russell and 
Bass, 1985). 
 The effect of dietary fiber is related to viscosity and methods of administration.  
The mechanism of action of gel-forming fiber is related to its ability to increase viscosity 
of gastrointestinal contents and thus interfere with motility and nutrient absorption (Sierra 
et al., 2002).  By lowering the viscosity of digesta, the rate of flow should be increased 
(McRorie et al., 1998).  If soluble polysaccharides are consumed as part of a dry or low-
moisture diet, their effect on digesta viscosity will be limited by their rate of dissolution 
and release, which in turn will depend upon the overall structure of the food and its 
susceptibility to mechanical and enzymatic degradation (Morris, 2001). 
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 In a study utilizing pigs, a relationship between viscosity of digesta and water 
content of digesta was observed (McRorie et al., 1998). It was concluded, therefore, that 
digesta viscosity is a function of water content when the diet is held constant.  
Furthermore, it was observed that when dry matter increases past 25%, a small increase 
in dry matter will result in a large increase in digesta viscosity (McRorie et al., 1998). 
 
Effects of Psyllium on Digestive Function and Metabolism 
 Viscosity.  Polysaccharides are hydrophilic, with an ability to hold water and 
undergo gelation.  The ability to hold water is due to the entrapment of water within the 
three-dimensional network of molecules.  Insoluble fibers hold water more like a sponge 
(Oakenfull, 2001).   
 The high water holding capacity of soluble fibers has an effect on their viscosity 
and their interactions with other molecules in the gut.  The high visco-elastic system 
provides roughage action, lubricates, and modifies absorption of certain nutrients.  
Psyllium is a particularly effective stool-bulking agent and is widely used in treatment of 
constipation and diarrhea.  The water holding capacity improves consistency of liquid 
stools, and the laxative effect is a result of its ability to form a gel and hold many times 
its own weight in water.  The water holding capacity affects stool weight and intestinal 
transit time (Blackwood et al., 2000).  Stool softening can be dramatically affected by 
relatively small increases in water content (McRorie et al., 1998). 
 
 Rate of Passage.  Psyllium hydrates in water to yield a viscous gel that could slow 
the gastric emptying of meal carbohydrates (Russell and Bass, 1985).  Using dogs, 
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researchers found that as test meal fiber content increased, gastric emptying was slowed.  
Psyllium, at 1% inclusion, produced the same stomach flow rate in duodenally cannulated 
dogs as did the saline control meal.  At 3% inclusion, however, the psyllium meals 
emptied slower, as if a constant amount of meal emptied per unit of time (Russell and 
Bass, 1985). Upper gut contractile activity regulates food transit through the small 
intestine, as well as the degree to which food is mixed with digestive enzymes and the 
exposure of digestive nutrients to the absorbing surface (Cherbut et al., 1994).   
 In humans, psyllium has been shown to ameliorate diarrhea (Washington et al., 
1998; Blumenthal et al. 2000), while during cases of constipation, psyllium has been 
shown to decrease passage time through increased stool volume (Blumenthal et al., 2000; 
Al-Assaf et al., 2003).  This effect in humans helps to restore and maintain regularity, 
and psyllium has been approved for use as a secondary medication for treatment of 
diarrhea (Blumenthal et al., 2000).  
 Inclusion of psyllium in the diet increases daily fecal mass.  Tomlin and Read 
(1998) observed increased fecal mass in humans consuming 14 g of psyllium per day and 
noted an inverse relationship between stool mass and transit time. Therefore, they 
determined that transit time and fecal mass are not necessarily dependent variables, and 
that stool frequency is more associated with transit time, not fecal mass (Tomlin and 
Read, 1998).  However, in rats, Leng-Peschlow (1991) found that colonic motility and 
propulsion of contents was influenced by load of material.  Furthermore, they observed 
that retention time determined the degree of digestion of fiber components (Leng-
Peschlow, 1991).  Fecal bulking results in decreased colonic transit time, thereby 
reducing exposure of colonic mucosa to intestinal contents (Edwards et al., 2003).   
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 In African green monkeys fed psyllium husk at 9.7% inclusion rate, a large day to 
day variation in fresh fecal output was noted (Costa et al., 1989b).  Psyllium significantly 
decreased fecal content of dry matter compared to monkeys on cellulose diets (Costa et 
al., 1989b).  In rats, fecal output increased with psyllium at 5% inclusion, which was 
attributed to increased fecal water and dry weight (Edwards et al., 1992).  Leng-Peschlow 
(1991) also observed increased fecal water and dry weights in rats fed psyllium.  
Asvarujanon et al. (2004) observed that fecal dry weights in rats were higher when fed 
psyllium; dry weights decreased as viscosity of psyllium preparations fed decreased.   
Additional hydration of stool by psyllium is an uncommon mechanism of laxation for a 
dietary fiber source, and is a feature used to treat loose stools (Marlett et al., 2000). When 
psyllium is included, it has been noted that feces tend to exhibit a gel-like quality in 
monkeys (McCall et al., 1992a), humans (Marlett et al., 2000), and calves (Cebra et al., 
1998). 
 In humans, feces are approximately 75% water and 25% dry matter, which is 
composed of undigested dietary residues plus bacteria and bacterial cell debris. The 
ability of fiber to increase fecal bulk depends on a complex relationship between the 
chemical and physical properties of the fiber and the bacterial population in the colon 
(Oakenfull, 2001).  Psyllium does not increase fecal bacterial mass in humans, but may 
increase stool frequencies (Marlett et al., 2000). Non-fermented fiber can absorb water, 
which increases fecal bulk and results in dilution of intestinal contents (Edwards et al., 
2003). Tomlin and Read (1998) concluded that the major mechanism by which soluble 
polysaccharides increased fecal mass is through increased water holding capacity, not by 
stimulation of bacterial growth.  An area of concern in some human studies is that 
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subjects have perceived increases in flatulence when taking psyllium, although others 
have not detected increased flatulence (Marlett et al., 2000).  
 In the study by Costa et al. (1989b), fecal viscosity was greater for psyllium-fed 
monkeys than for cellulose-fed monkeys.  The increase of viscosity in the psyllium-fed 
monkeys suggests that not all the psyllium was fermented, and that there may have been 
an increase in microbial mass.  The water-holding capacity of psyllium husk is high (3.2 
ml/g).  Due to the highly viscous nature of psyllium seen even in a 1% solution, a small 
unfermented portion could have caused increased fecal viscosity and weight (Costa et al., 
1989b).  
 McRorie et al. (1998) noted that when pigs were administered psyllium, the water 
content of the colon was significantly increased in 9 out of 13 bowel segments compared 
to control pigs fed no psyllium in the diet.  The 9 significant locations were located distal 
to the 4 non-significant yet numerically higher locations; therefore, the higher water 
holding capacity in pigs fed psyllium is most noted in the distal colon.  Consequently, it 
is concluded that psyllium resists the dehydrational effects of the distal colon, resulting in 
softer digesta and feces (McRorie et al., 1998).  
 
 Blood Cholesterol Reduction.  Psyllium is an effective blood cholesterol-lowering 
agent in human studies (Blackwood, 2000; Blumenthal et al., 2000; Sierra et al., 2002), 
as well as in rats (Asvarujanon et al., 2004). The proposed mechanism for cholesterol 
reduction is the adsorption of bile acids to dietary fiber through a large number of weak 
binding sites on the polysaccharide structure.  This adsorption of bile acids leads to 
increased fecal excretion of bile acids.  In turn, there is an increased metabolism of 
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cholesterol to bile acids in the liver, therefore removing more serum cholesterol and thus 
decreasing serum cholesterol concentrations (Blackwood et al., 2000).  
 To test this theory, Marlett and Fischer (2002) performed a study using 
colectomized rats fed 5% psyllium or 3.5% fraction B of psyllium compared to control 
colectomized rats.  They observed that the viscous fraction B is the primary active 
component of psyllium seed husk that interferes with bile acid absorption and increases 
water holding capacity of colon contents, thus supporting the theory of dietary fiber and 
bile acid adsorption.  
 
 Intestinal Glucose Transport.  Psyllium has been shown to slow the rate of 
monosaccharide absorption, in turn decreasing blood glucose concentrations, including 
the postprandial blood glucose increase (Blumenthal et al., 2000). Glucose absorption 
decreased in type 2 diabetic patients when psyllium was consumed (Sierra et al., 2002).  
Improvement in glucose tolerance produced by consumption of viscous fiber is more 
likely due to slower absorption of carbohydrate rather than decreased absorption.  
Intimate mixing, allowing physical interaction between food and fiber, seems to be 
important in slowing the rate of carbohydrate release and absorption (Sierra et al., 2002).  
Absorption of glucose depends in part on intestinal contractions that ensure mixing of 
luminal contents and create convective currents to bring nutrients from the bulk phase 
towards the epithelium.  In addition, the impact of psyllium on transit time in the small 
intestine may alter glucose contact time with absorptive surface (Cherbut et al., 1994). 
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 Gastrointestinal Electrical Activity.  Movement of digesta throughout the 
digestive tract depends on contractions (peristalsis) initiated by regular electrical 
impulses.  Postprandial activity is defined as myoelectrical activity recorded between 
meal ingestion and the first phase-three activity following meal ingestion.  Phase three of 
the migrating motor complex was defined as regular occurrences of spike bursts at a 
frequency of 10-12 cycles per minute.  Rushes consist of high amplitude electrical 
activities (> 200 mV), and minute rhythms consisted of low amplitude electrical activities 
(<100 mV).  In a study using human volunteers, researchers compared test meals 
containing glucose or glucose plus psyllium on small intestinal motility and blood 
glucose response (Cherbut et al., 1994). Psyllium induced longer and faster (i.e., higher 
velocity) propagations of rushes and minute rhythms than the non-supplemented glucose 
meal.  Psyllium reduced the occurrence of stationary activity and simultaneously 
increased the propagation length and velocity of propagated activity, therefore changing 
the patterns of propagated and stationary myoelectrical activity. These changes in 
postprandial activity could be related to physiochemical properties, including water 
holding capacity, and the increasing volume of gastrointestinal contents.  Luminal 
volume is one of the numerous factors controlling gastrointestinal motility. 
Mechanoreceptors in the visceral wall are excited by distension, which modifies gastric 
and small intestinal motility (Cherbut et al., 1994). 
 
 Nutrient Absorption.  The gel matrix of psyllium may slow absorption of nutrients 
or bile acids by trapping them within the matrix, thereby slowing mixing and diffusion in 
the intestine.  Psyllium may also slow the rate of enzymatic breakdown of dietary 
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constituents.  In addition, polysaccharides have the ability to bind other polar molecules 
and ions.  Ions may be released and absorbed as fiber is broken down in the colon 
(Oakenfull, 2001). 
 Viscous polysaccharides can cause delayed gastric emptying and slower transit 
through the small bowel, resulting in a reduced rate of nutrient absorption.  Psyllium 
increases the viscosity of intestinal contents, and therefore decreases the rate of 
absorption of bile acids, glucose, and other nutrients and allowing their absorption along 
a greater length of the small intestine (Blackwood et al., 2000).  Polysaccharides with 
large hydrophobic surface areas have potentially important roles in binding of bile acids, 
carcinogens, and mutagens (Blackwood et al., 2000). Psyllium also has been shown to 
interact with intestinal absorption of medications taken simultaneously, resulting in 
delayed intestinal absorption (Blumenthal et al., 2000). 
 Viscosity is a factor affecting mineral absorption in rats; the viscous property of 
psyllium therefore is a factor in mineral absorption.  For example, highly viscous 
psyllium appears to decrease absorption of calcium and magnesium (Asvarujanon et al., 
2004).  Psyllium did not affect mineral or vitamin A or E concentrations in human type 2 
diabetic patients (Sierra et al., 2002).  In African green monkeys, psyllium did not impair 
fat absorption (McCall et al., 1992a). 
  
 Intestinal Morphology.  Soluble fibers (including psyllium) are noted for their 
effect on the stomach and small intestine whereas insoluble fibers are noted for their 
effect on the large intestine, although some carbohydrates (such as psyllium) have an 
effect on both (Blackwood et al., 2000).  The arabinoxylan component of psyllium 
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stimulates microfloral growth and VFA formation.  In addition, the arabinoxylan can 
generate low molecular weight materials that are especially effective substrates for VFA 
production.  In turn, VFA production alters intestinal morphology and maintains a 
healthy digestive tract that can adsorb nutrients and molecules such as bile acids (Al-
Assaf et al., 2003). 
 Numerous studies have determined the effects of dietary psyllium inclusion on 
intestinal size, scale, and musculature.  In rats fed psyllium, the length of the small 
intestine (Leng-Peschlow, 1991) and large intestine (Leng-Peschlow, 1991; Edwards et 
al., 2003) were increased. Rats fed psyllium husks at a 4% inclusion rate had increased 
weights of small intestine, small intestinal mucosa, and cecum compared to a control 
group that did not receive psyllium (Schneeman and Richter, 1993). Colonic wet weight 
in rats increased with inclusion of psyllium in the diet (Edwards et al.. 1992). Leng-
Peschlow (1991) observed that dietary psyllium increased tissue weight per 100 mm of 
length in middle and lower parts of the small intestine and colon of rats.  Furthermore, 
mucosal thickness of the distal small intestine and villous height increased (Leng-
Peschlow, 1991).   
 In rats fed psyllium at 4% inclusion, smooth muscle thickness was not impacted 
in the duodenum; however, smooth muscle thickness in the ileum was increased 
(Schneeman and Richter, 1993).  In addition, the ratio of ileal and duodenal cells per villi 
was higher in the psyllium group than the control group, suggesting that the ileal cells 
were exposed to more nutrients.  This greater smooth muscle thickness in the psyllium 
group could be indicative of some degree of muscle hypertrophy associated with the 
more viscous nature of these polysaccharides in the gut lumen.  With age, absorptive 
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function in the proximal intestine appears to diminish.  A benefit of viscous 
polysaccharides for maintaining gut function could be that from an early age, the ileum 
absorbs more nutrients, and thus the addition of fiber facilitates this age-related 
adaptation (Schneeman and Richter, 1993). 
 The swelling properties of fibers influence the mass of intestine; therefore, 
increasing volume of contents seems to be important factors in influencing mass of bowel 
wall.  Psyllium has high water binding capacity, and swells early in gastrointestinal tract 
(Leng-Peschlow, 1991). 
 
 Production of Volatile Fatty Acids.  The main end products of colonic 
fermentation are the VFA acetic, propionic, and butyric acids, and the gases carbon 
dioxide, hydrogen, and methane (Blackwood et al., 2000).  One key property of fraction 
B is its resistance to fermentation by intestinal microflora (Fischer et al.. 2004). 
 Cultures inoculated with microbial cells in fecal and colonic samples from 
monkeys fed psyllium exhibited higher viscosities than from those fed cellulose.  This 
greater viscosity can be attributed to the hydrophilic properties of psyllium as discussed 
earlier.  Increased VFA production in the culture containing psyllium was attributed to 
the high content of arabinoxylan (Costa et al., 1989a). 
 Fermentation supports increased bacterial mass by producing VFA.  Production of 
VFA decreases colonic pH (Edwards et al., 2003).  Total amounts of acetate increased in 
cecal contents and feces of rats fed psyllium (Leng-Peschlow, 1991).  The VFA produced 
from psyllium fermentation stimulate mucosal proliferation and may contribute to 
structural and functional integrity of the mucosa (Leng-Peschlow, 1991).   Fermentation 
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of psyllium and resultant production of VFA also may have important metabolic 
implications (Edwards et al., 1992).  Energy is salvaged in the large bowel from 
undigested carbohydrates through fermentation (Edwards et al., 2003).   The VFA are 
believed to be trophic agents for colonic mucosa, and may be used as a preferential 
energy source by the colonic epithelial cells (Edwards et al.. 1992).  Total fecal VFA 
output increased with psyllium dose.  Psyllium ingestion resulted in a higher fecal 
concentration of propionic acid.  Propionic acid is thought to inhibit cholesterol synthesis 
in the liver (Edwards et al.. 1992).  Fecal VFA concentration was higher in psyllium-fed 
monkeys (9.7% inclusion) than cellulose-fed monkeys, with no differences in fecal VFA 
profile (Costa et al.. 1989b).  The same trend was exhibited in a culture system from the 
same monkeys (Costa et al.. 1989a).  Colonic VFA concentration was higher in psyllium-
fed monkeys than in cellulose-fed monkeys.  Colonic contents of psyllium-fed monkeys 
also had a lower percentage of dry matter compared to the cellulose fed monkeys (Costa 
et al.. 1989b); this trend also was exhibited in a culture system using inoculant from the 
same monkeys (Costa et al.. 1989a). 
 The effect of dietary fiber on fecal bulking is due to the presence of indigestible 
residue and the water binding capacity of that residue; bacterial mass depends on amount 
of fermentable substrate in large intestine. Psyllium, as a highly soluble fiber, is digested 
to an extent of 70-90% by large intestinal microflora (Leng-Peschlow, 1991), with the 
remaining percentage resistant to colonic bacterial degradation (Washington et al.. 1998; 
Marlett et al., 2000).  Some laxation effects of dietary fiber may be due to the VFA 
produced by fermentation (Oakenfull, 2001).   
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 In rats fed a diet containing fermentable fiber, it has been suggested that VFA 
increase daily epithelial cell production rate. This increased rate (3-4 times more 
epithelial cells produced per day) compared with the fiber-free diet could lead to an 
equivalent increase in epithelial cell loss, thereby increasing endogenous fecal nitrogen 
excretion (Sakata, 1987). 
 In canines, enterocytes oxidized more glucose, butyrate, and glutamine compared 
to colonocytes.  The colonocytes preferred to oxidize butyrate and glucose over 
glutamine, and glutamine over propionate. However, if other substrates are limiting, 
canine enterocytes and colonocytes have the capability to oxidize propionate in large 
quantities (Beaulieu et al., 2002). 
 In ruminants, VFA are not utilized well in the small intestine, and these tissues 
prefer to utilize glucose, glutamine, and ketones as primary energy sources.  Butyrate, 
acetate, and propionate are the three most utilized VFA in the colon, similar to the rumen.   
Butyrate has been shown to increase growth of both rumen and colonic tissues.  Glucose 
and glutamine can be utilized by colonocytes as energy substrates, but not with the same 
affinity as butyrate (Britton and Krehbiel, 1993).  Butyrate is a preferred oxidative fuel of 
the colonic epithelium and has the most profound effect on colonocyte growth and 
differentiation.  Instillation of VFA into the colonic lumen induces mucosal regeneration, 
as shown by increased weight, DNA content, and crypt length.  These effects are 
predominantly a result of butyrate (Velazquez, 1996).  In a study using adult sheep, 
Sakata and Tamate (1978) observed that there may be many stimulatory effects of 
butyrate on cell proliferation of the rumen epithelium.  Sakata and Tamate (1978) noted 
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that rapid administration of butyrate into the rumen stimulated proliferation of the rumen 
epithelial cells.  
 Bartholome et al. (2004) observed an effect of butyrate on the intestinal 
epithelium in neonatal piglets.  The piglets utilized in the study had undergone massive 
bowel resection and were maintained by total parenteral nutrition.  Treatments consisted 
of no supplementation with VFA (control) or supplementation with a VFA mixture (36 
mmol/L acetate, 15 mmol/L propionate, and 9 mmol/L butyrate), with 9 mmol/L 
butyrate, or with 60 mmol/L butyrate.  Butyrate was the VFA responsible for intestinal 
growth because effects of 9 mmol/L butyrate were very similar to the effects noted with 
the mixture of acetate, propionate, and butyrate (Bartholome et al., 2004).  Effects 
observed were increased villus height in the duodenum, jejunum, and ileum, and 
consequently increases in villus surface area.  Therefore, Bartholome et al. (2004) 
concluded that the supplementation of parenteral formulas with butyrate may aid in 
maximizing intestinal absorptive area in piglets.  
 
 Intestinal Microbiota.  Bifidobacterium and Lactobacillus are two genera of 
bacteria that have been shown to be of benefit when administered to newborn calves and 
piglets (Abe et al., 1995).  Bifidobacterium has been shown to be beneficial in humans, 
and may be a component of the intestinal flora of animals as well.  The uses of 
Bifidobacterium and Lactobacillus as probiotics in calf feeds could provide favorable 
benefits when consumed by young animals.  A series of studies evaluated probiotic use in 
neonatal calves and piglets (Abe et al., 1995).  The two probiotics fed were 
Bifidobacterium pseudolongum and Lactobacillus acidophilus.  The two probiotics were 
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fed separately along with a control group.  The two groups receiving probiotics were not 
different from one another, but bodyweight gain increased and frequency of diarrhea 
decreased when probiotics were fed compared with the control groups. The conclusion 
reached was that the inclusion of probiotics may improve bodyweight gain, feed 
conversion, and health of livestock through establishment of beneficial gut microflora.  
These bacteria would then inhibit the growth of pathogenic bacteria in the intestine (Abe 
et al., 1995).  The potential for psyllium to act as a prebiotic by stimulating beneficial 
microbial populations in the gastrointestinal tract has not been well researched.  
 
 Feed Intake.  Rats fed diets containing psyllium at 5% of diet tended to eat more 
food to account for dilution of energy by the fiber (Edwards et al., 1992).  Ingestion of 
increasing amounts of dietary fiber may lead to stomach distension, and viscous 
polysaccharides may slow the rate of gastric emptying (Oakenfull, 2001).  Effects of 
psyllium on feed intake are not well characterized. 
 
Psyllium and Neonatal Dairy Calves 
 Based on the literature discussed, psyllium could potentially have desirable 
effects in neonatal calves. Research involving psyllium inclusion in calf milk replacers is 
extremely limited. Current applications of psyllium to dairy calves appear to be confined 
mainly to treatments for diarrhea (scours).   
 Fettman (1992) postulated potential benefits of psyllium for treatment of neonatal 
calf diarrhea.  These benefits included moderation of gastric emptying, which in turn 
would reduce the rate of glucose absorption and thereby result in increased efficiency of 
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glucose disposal via the insulin-mediated response. Theoretically, carbohydrate tolerance 
would be improved as well as an increase in efficiency of nutrient absorption.  
Furthermore, inclusion of psyllium could increase VFA production, specifically butyrate.  
In turn, butyrate may have a glucose-sparing effect in the lower intestinal tract.  The 
glucose-sparing effect could occur by butyrate being more preferentially taken up into the 
TCA cycle, as opposed to pyruvate derived from glucose metabolism.  In addition, the 
increase in VFA production could stimulate epithelial proliferation and morphological 
integrity (Fettman, 1992).  Fettman's (1992) theories have been minimally tested in 
calves, but seem to have potential in light of the aforementioned research in monogastric 
species. 
 Naylor and Liebel (1995) examined the effects of psyllium in calves with scours. 
Using 10 calves in a cross-over design, they observed decreased glucose absorption in 
calves fed psyllium.  Therefore, they concluded that the inclusion of psyllium did not 
improve glucose absorption and resulted in no other benefits (Naylor and Liebel, 1995).   
 A second study examined treatment of scours with solutions containing psyllium.  
Cebra et al. (1998) supplemented scouring calves with a commercial electrolyte solution 
either with or without psyllium for 3 days.  Within 12 hours of consuming the electrolyte 
solution containing psyllium the calves' feces became gelatinous and viscous compared to 
the control calves.  Furthermore, peak glucose and insulin values were lower on day 1 for 
the calves consuming psyllium. However, the researchers concluded that the inclusion of 
psyllium did not yield enough benefits to merit a recommendation for its use in 
treatments for neonatal calf scours (Cebra et al., 1998).  
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 Miller and DeGregorio (1996) performed two studies with varying rates of 
psyllium inclusion in neonatal dairy calves. They found that inclusion of psyllium 
resulted in a "protein sparing effect" as calculated by protein efficiency.  Protein 
efficiency was calculated as body weight gained divided by crude protein consumed. 
Miller and DeGregorio (1996) concluded that inclusion of psyllium in calf milk replacers 
results in more efficient utilization of protein in milk replacer.  Therefore, inclusion of 
psyllium could allow for lower protein content in calf milk replacer for the same 
efficiency of gain (Miller and DeGregorio, 1996). 
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Chapter 2 
Effects of inclusion of psyllium in milk replacer on growth, rate of passage, digesta 
viscosity, nutrient digestibilities, and blood parameters in neonatal dairy calves 
 
Introduction 
In recent years, more attention has been focused on improving the health, growth, 
and development of neonatal dairy calves. A major challenge to young calves is gut 
health. According to the National Animal Health Monitoring Systems Dairy 2007 Report 
(National Animal Health Monitoring System, 2007), 56.5% of unweaned heifer deaths 
can be attributed to scours (diarrhea) or other digestive challenges.  Psyllium has been 
shown in other species to ameliorate diarrhea (Washington et al. 1998; Blumenthal et al. 
2000, Marlett et al. 2000) and decrease passage time during cases of constipation 
(Blumenthal et al., 2000; Al-Assaf et al. 2003).  Dietary fiber has been shown to limit the 
rate of release of nutrients through increasing the viscosity of the digesta, therefore 
reducing the rate of nutrient transport to the epithelium (Morris, 2001) and allowing 
nutrient absorption along a greater length of the small intestine (Blackwood et al., 2000). 
In dogs, inclusion of psyllium at 3% slowed digesta outflow from the stomach (Russell 
and Bass, 1985). Psyllium inclusion increases the viscosity of intestinal contents, thereby 
reducing the rate of absorption of glucose and other nutrients (Blackwood et al., 2000).  
Psyllium has been shown to decrease the post-prandial increase of blood glucose 
concentration (Blumenthal et al., 2000). If these effects occurred in young calves 
supplemented with psyllium it might translate to improved health and greater growth 
efficiency. 
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The purpose of this research was to determine the impact of psyllium inclusion in 
milk replacer on feed intake, water intake, growth, illness, digesta viscosity, rate of 
passage, nutrient digestibilities, and blood components in neonatal dairy calves. 
 
Materials and Methods 
Animal Care 
 All procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee (protocol number 04083).   
 The study occurred in two periods, the first (May 2004) using 12 calves and the 
second (June 2004) using 22 calves.  Male Holstein calves were purchased from Stone 
Ridge Dairy (Bellflower, IL) at less than 36 h of age.  
 At the beginning of the trial period, daily late afternoon trips were made to Stone 
Ridge Dairy to select and purchase calves.  At Stone Ridge Dairy, all male Holstein 
calves less than 36 h of age in the calf pack were evaluated for potential purchase by trial 
personnel.  The evaluation included body temperature, heart and lung auscultation, 
hydration status, mobility, navel status, and overall thriftiness. Also, the calves must have 
received at least one feeding of colostrum by Stone Ridge personnel. Calves deemed 
satisfactory were then transported to the University of Illinois Dairy Nutrition Field 
Laboratory (ca. 42 km).   
 Upon arrival, each calf received an eartag in the left ear for identification 
purposes.  Calves were then measured for withers height, body length, heart girth 
circumference, and body weight.  Ear notches were taken from each calf and placed in 
formalin for determination of persistently infected bovine viral diarrhea (PI-BVD) status.  
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Each calf was vaccinated against infectious bovine rhinotracheitis virus and 
parainfluenza-3 intranasally (2 ml of TSV-2; Pfizer Animal Health, Exton, PA). In 
addition, calves received 15 mL of Quatracon-2X Antiserum (Boehringer Ingleheim 
Vetmedica, Inc.; St. Joseph, MO) subcutaneously in the neck.  Each calf also received 2 
mL of Excenel (Pfizer Animal Health; Exton, PA) subcutaneously in the neck for the first 
3 d of the study.   After entry injections, the calves were moved to southward-facing 
individual calf hutches (Calf-Tel; Hampel Corp., Germantown, WI) on 15 to 20 cm of 
crushed limestone located on the south side of the Dairy Nutrition Field Laboratory.  No 
bedding was used, to minimize ingestion of bedding material that might confound 
treatment inferences. 
Assignment to Treatments 
 Calves were blocked by pairs based upon birth date, body weight, and total 
protein score and then randomly assigned within pair to each of the dietary treatments.  
These pairs of calves were then randomly assigned to harvest week.  Of the 34 calves 
assigned to treatments, 1 calf died at 2 d of age.  Necropsy results (University of Illinois 
College of Veterinary Medicine, Urbana, IL) indicated that the likely cause of mortality 
was related to birth trauma.  All other calves completed the trial in good health.  
Feeding 
 On the night of arrival, each calf was offered colostrum for ad libitum intake.  On 
the morning following arrival, each calf again was offered colostrum.  Treatment 
feedings were administered at 0600 and 1800 h.  Calves were fed milk replacers 
reconstituted to 12.5% dry matter (DM) at a rate of 12% of bodyweight (BW) daily, 
adjusted weekly as calves grew.  Milk replacers (Land O’Lakes Animal Milk Products 
  30 
 
Co., Arden Hills, MN) without (CON) or with 1.1% psyllium (PSY) were formulated to 
contain 22% protein and 20% fat, and contained only milk proteins.  Neither milk 
replacer contained growth-promoting antibiotics. Water was available to calves for ad 
libitum consumption, with fresh warm water provided twice daily after each milk 
replacer feeding.  No other feeds were offered. 
Health Monitoring 
 Calves were observed at least twice daily for general health, including appearance 
(alertness), appetite (ability to consume feed), and fecal scores.  Fecal scores were 
recorded daily, using the following guidelines:  1 = dry, hard; 2 = soft, formed; 3 = 
pudding-like; 4 = mix of liquids with some solids; and 5 = liquid.  If the calf’s hydration 
status was low (skin tenting evident), 500 mL of Lactated Ringers Solution (Abbott 
Laboratories; Abbott Park, IL) was administered subcutaneously.   If a calf appeared 
unhealthy, 3 mL of Excenel (Pfizer, Exton, PA) was administered subcutaneously for a 
period of 3 d.  If body temperature was over 39° C, 1 mL of Banamine (Schering-Plough 
Animal Health; Union, NJ) was administered subcutaneously. Calves received a booster 
of TSV-2 at 2 wk of age.  
Body Growth Measurements 
 Calves were weighed weekly prior to the evening feeding on the same day each 
week.  Growth measurements including heart girth, withers height, body length, and heart 
girth were made at the same time. 
Blood Sampling 
 Blood samples were collected weekly 1 h before feeding and 3 h post-feeding on 
the same day that body measurements were made.  Samples were obtained via jugular 
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venipuncture using 20-gauge needles (Becton Dickinson; Franklin Lakes, NJ) into 10-mL 
vacutainer tubes containing sodium heparin (Becton Dickinson; Franklin Lakes, NJ).  
Tubes were placed on ice and then centrifuged within 2 h of collection at 1300 rpm for 15 
min in an Eppendorf model 5804 centrifuge with swinging buckets (Brinkmann 
Instruments; Westbury, NY).  After centrifugation, the plasma was removed and aliquots 
placed into 5-mL Falcon tubes (Becton Dickinson; Franklin Lakes, NJ) at -20
o
C until 
analysis.   
 Aliquots of pre- and post-prandial plasma were analyzed for concentrations of 
NEFA (kit number 990-75409; Wako Pure Chemical Industries, Ltd., Osaka 541, Japan) 
with procedural modifications by Johnson and Peters (1993).  Concentrations of glucose, 
total protein, cholesterol, β-hydroxybutyrate (BHBA), and urea nitrogen were determined 
by enzymatic procedures in an auto-analyzer (University of Illinois Clinical Pathology 
Laboratory, Urbana, IL). 
Calf Harvest Procedure 
 Pairs of calves were harvested for analysis weekly.  For period 1, 2 calves were 
euthanized after arrival before experimental treatments began (week zero) for baseline 
measurements.  For the remaining weeks, one pair of calves was euthanized weekly, with 
the exception of week 4.  In week 4 of period 1, 4 calves were euthanized. For period 2, 4 
baseline calves were euthanized at week zero, and 2 pairs were euthanized during weeks 
1, 2, and 3.  For week 4, 5 calves were harvested due to the 1 mortality. 
 Calves were transported to the University of Illinois College of Veterinary 
Medicine at 0630 h. Calves were not fed their morning milk replacer prior to euthanasia. 
The harvest procedure consisted of the calf being administered Xylazine HCl 
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intramuscularly (50 mg/mL; Fort Dodge Animal Health; Fort Dodge, IA).  Once the calf 
was sedated, it was euthanized with an intravenous overdose of sodium pentobarbital 
(Fatal Plus; Veterinary Laboratories Inc., Lenexa, KS) and then exsanguinated.  This 
method was utilized instead of captive bolt stunning to minimize epithelial sloughing, 
which potentially could negatively impact measurements of ion transport and 
histomorphological analyses (Shirazi-Beechey et al.; 1989). 
 When the calf was declared dead, the veterinarian opened the body cavity. The 
gastrointestinal tract was ligated at the caudal esophagus and rectum and removed as 
rapidly as possible without damaging the tract.  To prevent movement of digesta between 
compartments, the different segments of the gastrointestinal tract were identified and 
ligated.  The gastrointestinal tract was then divided into three portions: the stomach 
portion consisting of rumen, reticulum, omasum, and abomasum; the small intestine, 
consisting of duodenum, jejunum, and ileum; and the colon.  Each portion was processed 
by the respective team of personnel for tissue and digesta collection.   
Digesta Collection 
 Digesta was removed from the gastrointestinal tract and placed into Whirlpack 
bags (Nasco; Fort Atkinson, WI).  Aliquots were removed at the laboratory for DM 
determination, and samples for viscosity measurement were stored at -20°C until further 
analysis.  The DM of the digesta was determined by drying an aliquot in an oven at 
110ºC for 24 h. 
Total Fecal Collection: Digestibility and Rate of Passage 
 To determine rate of passage and digestibility, calves to be harvested at weeks 2, 
3, and 4 underwent total fecal collections for a period of 5 d.  Calves were fitted with 
  33 
 
canvas sheep fecal bags, modified slightly to account for differences in body structure.  
These canvas bags were lined with a plastic bag to obtain the feces excreted by the calf.  
 To determine the rate of passage, calves were dosed with Co-EDTA. The Co-
EDTA was prepared according to the methods of Uden et al. (1980).  The solution of Co-
EDTA (13.8% cobalt) was made by dissolving the dry material in distilled water at a rate 
of 17.05 g per L of water.  This solution was then mixed with the milk replacer fed to the 
calf at a rate of 10 mL per L of milk replacer. Calves consumed this marker for a period 
of 16 feedings, at which point marker administration ceased and the rate of passage 
portion of the total collection began.  
 The first 48 h of each total fecal collection period involved fecal collections every 
12 h.  After the last dose of Co-EDTA was consumed within the milk replacer, collection 
times shifted to every 6 h for the remaining 72 h of collection.  When feces were 
obtained, the plastic bag was placed within a second plastic bag and stored at -20ºC until 
further analysis.  
 Fecal Dry Weights.  Feces were dried individually in a forced-air oven at 60ºC 
until constant weights were achieved.  Dried feces from the first 48 h of collection were 
composited, while feces from the rate of passage portion were maintained individually.  
The dried feces were then ground through a 1-mm screen in a Wiley Mill (Thomas-
Wiley; Swedesboro, NJ).   
 Sampling and Analysis of Milk Replacers and Feces.  Each milk replacer was 
sampled weekly.  Subsamples were combined by treatment and period, and stored at -20° 
C until analysis could occur concurrently with the fecal analyses to determine apparent 
digestibility of DM, ash, crude protein, energy, and long-chain fatty acids.  One half of all 
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dried samples of feces (48-h composite and rate of passage samples) were composited to 
provide samples for analysis of absolute DM , crude protein, gross energy, long-chain 
fatty acids, and ash.   
 Absolute DM was determined in duplicate utilizing the AOAC (1975) method.  
Ash content was determined by combusting duplicate samples in a muffle furnace for 24 
h at 600ºC.  Crude protein was analyzed in duplicate with the Leco Nitrogen/Protein 
Determinator (model FP-2000; Leco Corporation, St. Joseph, MI) using Official Method 
992.15 (AOAC, 2000).  Gross energy was determined in duplicate via bomb calorimetry 
(1261 Isoperibol Calorimeter; Parr Instrument Co., Moline, IL; Parr Instrument Manuals).  
Long-chain fatty acids were determined by gas chromatography (Shimadzu GC 17-A; 
Shimadzu Scientific Instruments, Inc.; Columbia, MD) of methyl esters formed by acid-
catalyzed transesterification using the methods of Sukhija and Palmquist (1988), as 
described by Beaulieu et al. (2002).   
 Apparent digestibilities of DM, ash, crude protein, gross energy, and long-chain 
fatty acids were calculated as: ((nutrient consumed − nutrient in feces)/nutrient 
consumed) × 100. 
Rate of Passage Analyses 
 To determine rate of passage, concentrations of cobalt were measured in the feces 
voided from the calves once cobalt administration ceased.  Cobalt analysis followed the 
methods of Hart and Polan (1984).  Briefly, 20 mL of 0.05 M EDTA solution was 
combined with 0.2 g of dried feces, shaken for 30 min, and filtered through Whatman #4 
filter paper (Whatman International Ltd.; Florham Park, NJ). 
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 Samples were then quantified by atomic absorption spectroscopy (air and 
acetylene flame; Perkin-Elmer, Norwalk, CT). The percent Co in each sample was 
calculated as: 
 % Co =  ppm × dilution factor  × 100 
   Sample weight (g) × 1,000,000 
  The model y(t) = y(0) ∙ exp (-kt) was utilized to describe the disappearance of 
cobalt, where y is the amount of marker present at time t and k is the rate constant. The 
mean retention time (MRT) was then calculated as the reciprocal of k (Faichney, 1993).  
Viscosity 
 Viscosity of digesta samples was determined utilizing methods from Dikeman 
(2005).  Samples were allowed to warm to room temperature (23°C) and gently mixed 
with a metal spatula for 30 sec to homogenize the samples.  Aliquots (2 mL) of rumen, 
abomasal, and jejunal fluid were removed and used for viscosity measurement. Samples 
from the rumen, abomasum, and jejunum were analyzed in duplicate using a digital 
Brookfield viscometer (LV-DV-II+) with a Wells/Brookfield cone and plate extension, 
either the CP-40 or CP-41.  Colon samples were too viscous to obtain 2-mL aliquots.  
Therefore, a Brookfield LV spindle set (LV-1; LV-2; LV-3) was utilized with digesta 
being placed into 100-mL beakers with a diameter of 5 cm.  The data were collected by 
Wingather Data software collection program.  Samples were analyzed at six different 
speeds (0.3, 0.5. 1.0, 1.5, 2.0, and 3.0 rpm), and viscosity was calculated as a function of 
rpm over rpm range.  
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Statistical Analysis 
 Statistical analyses were conducted utilizing the Proc Mixed procedure of SAS.  
The data were analyzed as a randomized complete block design (SAS version 9.1; SAS 
Institute Inc.; Cary, NC), with period as a random effect. Effects of dietary treatment, 
week, and the interaction of diet and week were included in the model as fixed effects.  
Baseline calves were not included in the analysis, but means and standard errors are 
shown for comparison. Significant differences were declared at P < 0.05, and trends 
toward significant effects were noted at P <0.15.  
 
Results and Discussion 
The nutrient composition of the two diets is exhibited in Table 2.1. The milk 
replacers were formulated to contain 22% CP and 20% fat (Land O'Lakes, Arden Hills, 
MN). The PSY milk replacer was produced by addition of 1.1% psyllium to the CON 
milk replacer.  This inclusion of psyllium resulted in a slight dilution effect, which likely 
explains why the nutrient values for all ingredients except lactose and manganese were 
numerically lower in PSY than in CON.  
Water intakes did not differ significantly between treatments (Table 2.2). Intakes 
of DM, protein, and metabolizable energy (ME) also did not differ between diets.  Water, 
DM, protein, and ME intakes increased from wk 1 to 4 (P < 0.01) as expected (data not 
shown), but the diet × week interaction was not significant.  
The diet × week interaction was significant for body length (Table 2.3).  Body 
length tended to increase (P < 0.08) from wk 1 to 4 as expected, but increases during wk 
1 and 2 were greater for calves fed CON than for those fed PSY. Heart girth increased (P 
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< 0.01) from wk 1 to 4, but effects of diet and the diet × week interaction were not 
significant. Withers height was not affected by dietary treatment or age.  Body weights 
increased with age of the calves as expected, but dietary treatments did not affect BW.  
Inclusion of psyllium in the diet, therefore, had minimal impact on growth parameters in 
this study.  The ADG of BW was lower than those predicted by the NRC (2001) model 
(Table 2.3).  Possible reasons for this finding include the young age of the calves, the fact 
that calves had been transported, the degree of heat stress on the calves, and the impact of 
experimental procedures performed on the calves. 
Inclusion of psyllium in the calf milk replacer increased (P < 0.005) viscosities of 
abomasal and colon digesta (Table 2.4). Ruminal and jejunal digesta viscosities did not 
differ between treatments. Rumen viscosity increased from wk 1 to 4 (P < 0.08), but the 
diet × week interaction was not significant. The lack of difference in rumen viscosity is 
most likely attributable to the fact that the milk replacers mostly bypassed the rumen via 
the reticular groove in these pre-ruminant calves. Therefore, minimal milk replacer would 
enter the rumen and contribute to differences in rumen viscosity.  
Given the viscous properties of psyllium, it would be expected that the digesta 
from the PSY calves would exhibit greater viscosity throughout the gastrointestinal tract, 
as was seen in abomasal and colonic digesta.  The lack of difference in jejunal viscosity 
(Table 2.4) is intriguing. It is possible that pH or digestive secretions may have caused 
the lack of effect, but neither pH nor digestive secretions were measured in this study.  In 
pre-ruminant calves, the pH of digesta has been reported to range from 2.5 to 5.5 in the 
proximal small intestine, increasing as the digesta approaches the distal ileum (Guilloteau 
and Zabielski, 2005). However, the pH of abomasal digesta in pre-ruminant calves has 
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been reported to range from 2.5 to 5.5 (Guilloteau and Zabielski, 2005) or from 1.5 to 6.0 
(Davis and Drackley, 1998). This broader range for abomasal pH than jejunal pH 
challenges the potential effect of pH on the lack of viscosity differences in jejunal 
digesta. It has been shown that the pH swings of the abomasal digesta are related to meal 
feeding, with lower pH values pre-prandially and higher values post-prandially (Davis 
and Drackley, 1998). 
A trend (P < 0.11) was observed for increased mean retention time for calves fed 
the PSY milk replacer (Table 2.5). This increase in mean retention time for the PSY 
calves could be attributed to the increased viscosity of the digesta delaying gastric 
emptying, as observed in studies with other species (Russell and Bass, 1985; Washington 
et al., 1998). 
No significant differences were observed between treatments in DM content of 
rumen digesta (Table 2.6), probably because little milk replacer entered the rumen.  
Differences between diets also were not significant for digesta DM content of the 
abomasum and jejunum, although means were numerically lower for calves fed PSY. The 
digesta in the proximal colon (P < 0.02) and distal colon (P < 0.02) of calves fed PSY 
exhibited a lower DM content than in the CON calves, most likely due to the water-
holding capacity of psyllium. These data are similar to those of McRorie et al. (1998), 
who found that water content of the colonic digesta in pigs supplemented with psyllium 
was significantly increased in the 9 most-distal bowel segments of the 13 segments 
evaluated. They concluded that psyllium was able to resist the dehydrational effects of 
the distal colon, resulting in softer digesta and feces.  
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The PSY calves produced more fecal DM output than CON calves (P < 0.03; 
Table 2.7). Increased fecal output with dietary psyllium also has been observed in rats 
(Leng-Peschlow, 1991; Edwards et al., 1992; Asvarujanon et al., 2004).  Fecal DM 
content was significantly lower for the PSY calves (P < 0.01). Similar to the colonic 
digesta, lower fecal DM likely reflects the greater water-holding capacity of psyllium 
increasing the fecal water content as observed in monkeys fed psyllium (Costa et al., 
1989).  Furthermore, a gel-like quality was observed in the feces of PSY calves, 
supporting similar observations in monkeys (McCall et al., 1992), humans (Marlett et al., 
2000), and calves (Cebra et al., 1998). 
The apparent digestibility of DM was greater (P < 0.027) for the CON calves 
(Table 2.7). Lower apparent digestibility of DM for calves fed PSY could be a result of 
the dilution effect of psyllium inclusion, which as a fermentable dietary fiber source is 
still less digestible than the other ingredients in milk replacer.  In addition, a significant 
treatment × week interaction (P < 0.035) was observed.  Differences between treatments 
were greatest during wk 2 and least during wk 3.  Similar dietary effects and interactions 
between dietary treatment and week were also noted for digestibilities of energy, ash, and 
CP (Table 2.7). 
The CON calves tended to have an increased ash digestibility when compared to 
the PSY calves, particularly during wk 2 and 4 (treatment × week interaction, P < 0.06). 
In rats, it has been shown that increased viscosity can decrease mineral absorption 
(Asvarujanon et al., 2004). The viscous nature of psyllium allows for entrapment of 
minerals within its matrix, thereby potentially decreasing absorption; however, this is an 
area that has not been extensively researched. Although psyllium has been shown to 
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decrease the rate of nutrient absorption (Blackwood et al., 2000), effects on the extent of 
absorption are not fully understood.  
No significant effects of treatment (P ≥ 0.63) were observed for digestibilities of 
the long-chain fatty acids C16:0, C18:0, C18:1cis, or total fatty acids (Table 2.7).  
However, an effect of week was noted for C16:0 (P < 0.03) and C18:0 (P < 0.03) because 
digestibilities increased with age.  No diet × week interactions were noted for fatty acid 
digestibilities. 
Psyllium has been used in humans to slow the rate of glucose absorption and to 
blunt the post-prandial increase in blood glucose (Blumenthal et al., 2000, Sierra et al.¸ 
2002).  In our study, there was no difference in post-prandial glucose concentrations 
between the PSY and CON treatments (Table 2.9). However, there was a tendency (P < 
0.064) for the PSY calves to have higher blood glucose concentration pre-prandially (i.e., 
10 h post-prandial, Table 2.8). This finding could be the result of the viscous nature of 
psyllium slowing the rate of glucose absorption over a longer period of time. It is also 
possible that the CON calves had a higher insulin response to dispose of elevated glucose 
concentrations post-prandially, but blood insulin concentrations were not measured in 
this study. 
Concentrations of NEFA, BHBA, cholesterol, urea N, and total protein were not 
different between treatments either pre-prandially (P ≥ 0.28; Table 2.8) or post-prandially 
(P ≥ 0.44; Table 2.9). However, an effect of week (i.e., age of calves) was observed for 
pre-prandial values of NEFA (decrease, P < 0.01), BHBA (increase, P < 0.08), and 
cholesterol (increase, P < 0.001). Furthermore, an effect of week was also observed for 
post-prandial values of NEFA (decrease, P < 0.01), BHBA (increase, P < 0.001), 
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cholesterol (increase, P < 0.001) and total protein (decrease, P < 0.02). A tendency 
toward a diet × week interaction (P < 0.12) was detected for cholesterol in pre-prandial 
plasma, but the interpretation is unclear.  No significant treatment × week interactions 
were observed (P ≥ 0.18) in post-prandial plasma samples. 
 
Conclusions 
The moderation of blood glucose concentrations with psyllium in the diet is an 
interesting finding to consider in neonatal dairy calves, particularly as it pertains to 
efficiency of growth. Whether these effects would be observed in calves also fed starters 
is an area for future research.  
The increase in viscosity of digesta and increase in MRT could potentially be of 
benefit to neonatal dairy calves raised in environments where infectious challenges were 
more prevalent or once calf starter consumption begins. Altered digesta flow could 
potentially allow for increased digestibility of the diet, despite the fact that minimal 
differences in digestibility of milk replacer were observed in this trial. Although psyllium 
did not affect growth or health of calves in this study, the physiological changes observed 
suggest that effects of psyllium supplementation should be tested in large numbers of 
calves. It would also be of interest to evaluate digestibilities and growth of dairy calves 
fed larger amounts of milk replacer with calf starter, as opposed to this trial in which only 
limited amounts of milk replacer were fed. Therefore, psyllium use is potentially of 
benefit in the field provided it is economically feasible, and should be further researched 
in a typical dairy calf raising situation.   
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Table 2.1  Composition of milk replacers.
1
 
    
Nutrient Control (CON)  Psyllium (PSY) 
Dry matter, % 96.4  96.2 
Crude protein, % 21.8  21.6 
Crude fiber, % 1.65  0.85 
Lactose, % 33.0  34.0 
Crude fat, % 21.00  19.95 
Ash, % 
2
 11.8  11.7 
TDN, % 106.0  104.5 
Gross energy, (kcal/kg)
3
 4844  4822 
NEL, (Mcal/kg) 2.73  2.70 
NEM, (Mcal/kg) 2.99  2.95 
NEG, (Mcal/kg) 2.16  2.12 
Calcium, % 0.81  0.78 
Phosphorus, % 0.74  0.72 
Magnesium, % 0.13  0.13 
Potassium, % 2.24  2.16 
Sodium, %  1.24  1.20 
Iron, mg/kg 101  68 
Zinc, mg/kg 24  18 
Copper, mg/kg <1  <1 
Manganese, mg/kg 21  22 
Molybdenum, mg/kg 0.50  0.45 
Psyllium, % 
4
 0.00  1.10 
     
1 
Determined by Dairy One (Ithaca, NY) unless otherwise noted.  All values except dry matter (% as fed) 
are expressed on a dry matter basis. 
2
 Determined according to AOAC (1975). 
3 
Determined by bomb calorimetry (Parr Instrument Co., Moline, IL). 
4
 As reported by manufacturer (Land O'Lakes Animal Milk Products; Arden Hills, MN). 
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Table 2.2 Least squares means and associated standard errors for water, dry matter, and 
nutrient intakes. 
  Overall diet means  P
1
 
Intake   CON PSY SE   T W T*W 
Water, L         
   Morning  2.15 2.16 0.19  0.99 <.0001 0.44 
         
   Night  1.21 1.58 0.21  0.12 0.01 0.30 
         
   Daily  3.32 3.47 0.33  0.75 <.0001 0.28 
         
DMI, g/d  712 732 21.7  0.31 0.001 0.98 
         
Protein, g/d  155 158 4.7  0.50 0.013 0.98 
         
ME, kcal/d  3175 3105 95  0.39 0.013 0.98 
         
                  
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON = Control diet 
3 
PSY = Psyllium-supplemented diet 
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Table 2.3 Least squares means and associated standard errors for average daily growth. 
  Overall diet means  P
1
 
Variable   CON
2
 PSY
3
 SE   T W T*W 
         
Body length, cm/d  0.20 0.12 0.05  0.17 0.08 0.04 
         
Heart girth, cm/d  0.19 0.17 0.04  0.76 0.01 0.94 
         
Withers height, cm/d  0.22 0.19 0.05  0.71 0.85 0.69 
         
Body weight, kg/d  0.29 0.27 0.04  0.66 <.001 0.82 
         
Predicted BW gain
4
, kg/d  0.54 0.55 ---     
         
                  
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON=Control diet 
3 
PSY= Psyllium-supplemented diet   
4 
Predicted average daily gain according to NRC (2001). Not analyzed statistically, but shown for 
information purposes. 
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Table 2.4 Least squares means and associated standard errors (centipoise, cP) for viscosity of 
digesta. 
  Overall diet means  P
1
 
Variable   CON
2
 PSY
3
 SE   T W T*W 
         
Rumen  10.17 8.80 0.98  0.33 0.08 0.25 
         
Abomasum  18.10 34.11 6.88  0.004 0.28 0.77 
         
Jejunum
4
  21.44 19.91 4.81  0.69 0.36 0.54 
         
Colon
4
  3.67 4.74 0.14  <0.001 0.16 0.24 
         
                  
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON=Control diet 
3 
PSY= Psyllium-supplemented diet 
4
 Data were Log10 transformed for statistical analysis, but back-transformed means are shown 
for ease of interpretation. 
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Table 2.5 Least squares means and associated standard errors for mean digesta retention 
time in the total tract. 
 Overall diet means   P
1
 
Location CON
2
 PSY
3
 SE   T W T*W 
              
Mean retention time, h 8.45 9.71 0.59  0.106 0.93 0.76 
        
                
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON=Control diet. 
3 
PSY= Psyllium-supplemented diet 
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Table 2.6.  Least squares means and associated standard errors for weekly dry matter 
contents (%) of gastrointestinal tract digesta. 
 Overall diet means  P
1
 
Location CON
2
 PSY
3
 SE   T W T*W 
         
Rumen 1.5 1.7 0.00  0.52 0.18 0.32 
        
Abomasum 3.8 2.7 0.01  0.28 0.30 0.52 
        
Jejunum 8.2 7.6 0.01  0.55 0.38 0.62 
        
Proximal colon 17.3 13.8 0.01  0.02 0.74 0.84 
        
Distal colon 20.9 17.8 0.01  0.05 0.10 0.65 
        
                
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON=Control diet 
3 
PSY= Psyllium-supplemented diet 
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Table 2.7.  Least squares means and associated standard errors for total tract apparent digestibilities. 
 Week 2 Week 3 Week 4 Overall diet means P
1
 
 Item CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                
5-d Total fecal output, 
g DM 184 257 27.8 213 243 27.8 196 258 24.1 198 253 15.4 0.023 0.96 0.72 
                
Fecal DM, % 21.8 16.6 1.7 18.7 16.2 1.7 21.2 16.9 1.5 20.6 16.5 0.01 0.007 0.48 0.71 
                
Digestibilities, %              
                
   DM  94.1
a
 91.2
b
 0.7 93.5 94.3 0.7 94.6
c
 93.0
d
 0.6 94.1 92.8 0.4 0.027 0.132 0.035 
                
   Energy  94.9
e
 92.6
f
 0.7 94.2 95.2 0.7 95.8
g
 94.5
h
 0.6 95.0 94.1 0.4 0.087 0.081 0.054 
                
   Ash  87.8
i
 82.5
j
 1.3 87.8 89 1.3 86.1
k
 83.9
l
 1.1 87.2 85.2 0.7 0.068 0.021 0.058 
                
   CP  86.1
m
 82.7
n
 1.7 83.5
o
 88.4
p
 1.7 88.5 87.7 1.5 86.3 86 1.1 0.84 0.057 0.049 
                
   C16:0 99.0 98.6 0.22 99.2 99.6 0.22 99.5 99.2 0.19 99.2 99.1 0.12 0.63 0.029 0.21 
                
   C18:0 96.4 95.8 0.79 98.9 97.5 0.79 98.5 97.8 0.69 97.5 97.5 0.44 0.95 0.028 0.31 
                
   C18:1cis 99.8 99.8 0.48 99.8 99.9 0.48 99.9 99.8 0.48 99.8 99.8 0.03 0.92 0.21 0.17 
                
   Total fatty acids 99.1 99.9 0.19 99.3 99.7 0.19 99.5 99.4 0.16 99.3 99.3 0.1 0.93 0.027 0.23 
                   
                                      
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2
 CON=Control diet 
3
 PSY= Psyllium-supplemented diet        
a,b
 Subcolumn means within row and week category with different superscripts differ (P <0.01). 
c,d,g,h
 Subcolumn means within row and week category with different superscripts differ (P <0.10). 
e,f,o,p
 Subcolumn means within row and week category with different superscripts differ (P <0.05). 
i,j 
Subcolumn means within row and week category with different superscripts differ (P <0.02). 
k,l 
Subcolumn means within row and week category with different superscripts differ (P <0.20). 
m,n 
Subcolumn means within row and week category with different superscripts differ (P <0.15). 
5
1
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Table 2.8  Least squares means and associated standard errors for weekly pre-prandial 
blood constituents. 
 Week 0 Overall diet means P
1
 
Variable Baseline
2
 SE CON PSY SE T W T*W 
Glucose, mg/dL 102.6 3.2 94.6 99.2 4.2 0.06 1.00 0.67 
         
NEFA 395 29.5 244 231 22 0.52 0.01 0.66 
         
BHBA, mmol/L 0.06 0.01 0.06 0.06 0.01 0.80 0.08 0.96 
         
Cholesterol, mg/dL 27.9 1.6 75.1 71.6 2.5 0.28 <.001 0.12 
         
Urea N, mg/dL 12.6 0.94 6.3 6.1 0.54 0.68 0.85 0.81 
         
Total protein, mg/dL 5.77 0.11 5.73 5.6 0.23 0.36 0.40 0.69 
                  
 
 
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2
 Baseline values are shown for informational purposes and are not included in the 
statistical analyses. 
3 
CON=Control diet. 
4 
PSY= Psyllium-supplemented diet 
 
 
  53 
 
 
Table 2.9  Least squares means and associated standard errors for weekly post-prandial blood 
constituents. 
 Week 0 Overall diet means P
1
 
Variable Baseline
2
 SE CON PSY SE T W T*W 
Glucose, mg/dL 103.6 4.23 102.5 105.7 2.8 0.42 0.073 0.87 
         
NEFA 261 22.4 191 185 12.6 0.73 0.013 0.52 
         
BHBA, mmol/L 0.05 0.01 0.02 0.02 0.01 0.45 <0.001 0.74 
         
Cholesterol, mg/dL 26.4 1.3 67.9 68.1 3.0 0.96 <0.001 0.18 
         
Urea N, mg/dL 12.0 0.98 6.2 5.8 0.73 0.44 0.89 0.64 
         
Total protein, 
mg/dL 5.10 0.43 5.13 5.10 0.61 0.99 0.018 0.76 
           
 
 
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2
 Baseline values are shown for informational purposes and are not included in the statistical 
analyses. 
3 
CON=Control diet 
4 
PSY= Psyllium-supplemented diet 
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CHAPTER 3 
Effects of inclusion of psyllium in milk replacer on volatile fatty acid concentrations, 
microbial populations, and gastrointestinal size in neonatal dairy calves 
 
Introduction 
 Psyllium has been studied in many species for its potential effects on digestive 
function, rate of passage, nutrient absorption, and intestinal morphology when added to 
the diet.  Neonatal dairy calves are subject to development of scours (diarrhea) and other 
gastrointestinal upsets, which contribute to the high rates of morbidity and mortality 
(National Animal Health Monitoring System, 2007).  The impact of psyllium on digestive 
function, rate of passage, and metabolism in young calves is not known. 
 As a fermentable fiber, psyllium would be expected to favor intestinal anaerobic 
bacteria with the capacity to ferment it.  Increased fermentation in the lower tract results 
in greater concentrations of VFA, which in turn increase mass of the gastrointestinal tract 
in other species such as rats (Leng-Peschlow, 1991; Edwards et al. 1992; Schneeman and 
Richter, 1993; Edwards et al. 2003).  A larger gastrointestinal tract with a more stable 
population of desirable bacterial species might improve growth and health in young dairy 
calves. 
 Little is known about the effects of supplementing psyllium to the diet of young 
calves.  The purpose of this portion of the study was to determine the effects of inclusion 
of psyllium in milk replacers on VFA concentrations and microbial populations 
throughout the gastrointestinal tract, as well as on size and scale of gastrointestinal tissues 
in neonatal dairy calves.  
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Materials and Methods 
Animal Care 
 All procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee (protocol number 04083).   
 The study was conducted during two periods, the first (May 2004) using 12 calves 
and the second (June 2004) using 22 calves.  Male Holstein calves were purchased from 
Stone Ridge Dairy (Bellflower, IL) at less than 36 h of age.  
 At the beginning of the trial period, daily late afternoon trips were made to Stone 
Ridge Dairy to select and purchase calves.  At Stone Ridge Dairy, all male Holstein 
calves less than 36 h of age in the calf pack were evaluated for potential purchase by trial 
personnel.  The evaluation included body temperature, heart and lung auscultation, 
hydration status, mobility, navel status, and overall thriftiness. Also, the calves must have 
received at least one feeding of colostrum by Stone Ridge personnel. Calves deemed 
satisfactory were then transported to the University of Illinois Dairy Nutrition Field 
Laboratory.   
 Upon arrival, each calf received an eartag in the left ear for identification 
purposes.  Calves were then measured for withers height, body length, heart girth 
circumference, and body weight.  Ear notches were taken from each calf and placed in 
formalin for determination of persistently infected bovine viral diarrhea (PI-BVD) status.  
Each calf was vaccinated against infectious bovine rhinotracheitis virus and 
parainfluenza-3 intranasally (2 ml of TSV-2; Pfizer Animal Health, Exton, PA). In 
addition, calves received 15 mL of Quatracon-2X™ Antiserum (Boehringer Ingleheim 
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Vetmedica, Inc.; St. Joseph, MO) subcutaneously in the neck.  Each calf also received 2 
mL of Excenel (Pfizer Animal Health; Exton, PA) subcutaneously in the neck for the first 
3 d of the study.   After entry injections, the calves were moved to southward-facing 
individual calf hutches (Calf-Tel; Hampel Corp., Germantown, WI) on 15 to 20 cm of 
crushed limestone located on the south side of the Dairy Nutrition Field Laboratory.  No 
bedding was used, to minimize ingestion of bedding material that might confound 
treatment inferences. 
Assignment to Treatments 
 Calves were blocked by pairs based upon birth date, body weight, and total 
protein score and then randomly assigned within pair to each of the dietary treatments.  
These pairs of calves were then randomly assigned to harvest week.  Of the 34 calves 
assigned to treatments, 1 calf died at 2 d of age.  Necropsy results (University Of Illinois 
College of Veterinary Medicine, Urbana, IL) indicated that the cause of mortality was 
likely related to birth trauma.  All other calves completed the trial in good health.  
Feeding 
 On the night of arrival, each calf was offered colostrum for ad libitum intake.  On 
the morning following arrival, each calf again was offered colostrum.  Treatment 
feedings were administered at 0600 and 1800 h.  Calves were fed milk replacers 
reconstituted to 12.5% DM at a rate of 12% of BW daily, adjusted weekly as calves grew.  
Milk replacers (Land O’Lakes Animal Milk Products Co.; Arden Hills, MN) with or 
without a 1.1% inclusion of psyllium were formulated to contain 22% protein and 20% 
fat, and contained only milk proteins.  Neither milk replacer contained growth-promoting 
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antibiotics. Water was available to calves for ad libitum consumption, with fresh warm 
water provided twice daily after each milk replacer feeding. No other feeds were offered. 
Health Monitoring 
 Calves were observed at least twice daily for general health, including appearance 
(alertness), appetite (ability to consume feed), and fecal scores.  Fecal scores were 
recorded daily, using the following guidelines:  1 = dry, hard; 2 = soft, formed; 3 = 
pudding-like; 4 = mix of liquids with some solids; and 5 = liquid.  If the calf’s hydration 
status was low (skin tenting evident), 500 mL of Lactated Ringers Solution (Abbott 
Laboratories; Abbott Park, IL) was administered subcutaneously.   If a calf appeared 
unhealthy, 3 mL of Excenel (Pfizer, Exton, PA) was administered subcutaneously for a 
period of 3 d.  If body temperature was over 39° C, 1 mL of Banamine (Schering-Plough 
Animal Health; Union, NJ) was administered subcutaneously. Calves received a booster 
of TSV-2 at 2 wk of age.  
Calf Harvest Procedure 
 Pairs of calves were harvested weekly for analysis.  For period 1, two calves were 
euthanized after arrival before experimental treatments began (wk 0) for baseline 
measurements.  For the remaining weeks, one pair of calves was euthanized weekly, with 
the exception of wk 4.  In wk 4 of period 1, four calves were euthanized. For period 2, 
four baseline calves were euthanized at wk 0, and two pairs were euthanized during wk 1, 
2, and 3.  For wk 4, five calves were harvested due to the one mortality. 
 Calves were transported to the University of Illinois College of Veterinary 
Medicine at 0630 h. Calves were not given their morning milk replacer prior to 
euthanasia. The harvest procedure consisted of the calf being administered Xylazine HCl 
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intramuscularly (50 mg/mL; Fort Dodge Animal Health; Fort Dodge, IA).  Once the calf 
was sedated, it was euthanized with an intravenous overdose of sodium pentobarbital 
(Fatal Plus; Veterinary Laboratories Inc., Lenexa, KS) and then exsanguinated.   
 When the calf was declared dead, the veterinarian opened the body cavity. The 
gastrointestinal tract was ligated at the caudal esophagus and rectum and removed as 
rapidly as possible without damaging the tract.  To prevent movement of digesta between 
compartments, the different segments of the gastrointestinal tract were identified and 
ligated.  The gastrointestinal tract was then divided into three portions: the stomach 
portion consisting of rumen, reticulum, omasum, and abomasum; the small intestine, 
consisting of duodenum, jejunum, and ileum; and the colon.  Each portion was processed 
by the respective team of personnel for tissue and digesta collection.   
Digesta Collection 
 Individual aliquots of digesta from the rumen, jejunum, and colon were placed 
into pre-weighed Cary-Blair transport media containers (Meridian Diagnostics; 
Cincinnati, OH).  The medium in the Cary-Blair allows for stabilization of anaerobic 
microorganisms prior to laboratory enumeration for Lactobacillus, Bifidobacteria, 
Clostridium perfringens, and E. coli.  
 For VFA sample collection, approximately 1 to 5 mL of digesta was placed into a 
pre-weighed Nalgene bottle (Nalge Nunc International; Rochester, NY) containing 10 
mL of 2 N HCl.  The bottles were then weighed again to determine amount of digesta 
placed into each bottle.  The samples were then stored at -20°C until analysis.   
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 After all digesta had been removed from the gastrointestinal tract, each section 
was rinsed.  Wet weights and lengths were measured and recorded for calculation of 
gastrointestinal size and scale parameters. 
Microbial Analyses 
 The procedure for enumeration of Bifidobacterium spp. was that of Muñoa and 
Pares (1988), utilizing Bifidobacteria agar (Difco Laboratories; Detroit, MI). 
Lactobacillus spp. were cultured on Rogosa SL agar (Difco Laboratories; Detroit, MI).  
Clostridium perfringens was cultured on Clostridia agar (Sigma-Aldrich; St. Louis, MO), 
utilizing the Food and Drug Administration Method #196 (1992).  E. coli were cultured 
on EMB agar (Difco Laboratories; Detroit, MI). 
 When digesta samples arrived at the laboratory, serial dilutions (10
-1
 through 10
-8
) 
in anaerobic diluent were made from the Cary-Blair media containing digesta according 
to the methods of Bryant and Burkey (1953).  Droplets of five appropriate dilutions were 
then inoculated onto their respective petri dishes for each of the four agars to maximize 
counting precision of the microbial colonies.  Each petri dish received 7 droplets of 10 μL 
each.  After droplets had been adsorbed into the sterile agar, plates for Bifidobacteria, 
Lactobacillus, and C. perfringens were inverted and incubated anaerobically (95% CO2 
and 5%H2) at 39°C.  E. coli plates were incubated aerobically at 37°C.  Colonies were 
counted after 24 to 48 h of incubation to determine colony forming units (CFU) per gram 
of sample.  Plates exhibiting 4 to 20 colonies per droplet were counted and averaged.  A 
CFU was defined as a distinct colony measuring at least 1 mm in diameter.  Colony 
forming units per gram sample (DM basis) were calculated as: 
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 CFU/g  =     (mean CFU) x (dilution) x (diluent dilution)   
         (g sample, DM basis) x (mL in droplet on culture plate)  
 
 
Volatile Fatty Acid Analyses 
 Samples of digesta collected from the rumen, abomasum, jejunum, proximal 
colon, and distal colon were prepared for analysis of volatile fatty acid (VFA) 
concentrations, using the methods of Erwin et al. (1961) with modifications. Briefly, an 
initial centrifugation (500 × g) of the samples was performed to remove particulate 
matter, using a Beckman centrifuge at 13,000 rpm with a JA-14 rotor.  Aliquots (4 mL) 
of the samples acidified in HCl were mixed with 1.0 mL of 250 g/L m-phosphoric acid, 
precipitated at room temperature for 30 min, and centrifuged at 20,000 × g.  The 
supernatant was decanted and frozen overnight at -20°C in microcentrifuge tubes. The 
supernatant was thawed and the microcentrifuge tubes were centrifuged at 13,000 × g for 
15 min using an Eppendorf 5804 centrifuge with an F-4S-30-11 rotor (Brinkmann 
Instruments; Westbury, NY).  Samples were centrifuged with centrifugal filters 
(Centricon 3000 MC; Millipore, Billerica, MA) to remove remaining particulate matter.  
The supernatants were then placed in gas chromatography vials (SUN-SRI; Duluth, GA) 
that were capped and refrigerated until concentrations of VFA were determined. 
 Concentrations of VFA in the supernatants were determined by gas-liquid 
chromatography.  Briefly, concentrations of acetate, propionate, butyrate, isobutyrate, 
valerate, and isovalerate were determined using a Hewlett-Packard 5890A Series II gas 
chromatograph (Palo Alto, CA) fitted with a glass column (180 cm × 4 mm i.d.) packed 
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with 10% SP-1200/1% H3PO4 on 80/100 mesh Chromosorb W AW (Supelco Inc., 
Bellefonte, PA).  Nitrogen was the carrier gas with a flow rate of 75 mL/min.  Oven 
temperature, detector temperature, and injector temperature were 125, 175, and 180ºC, 
respectively.  Concentrations of VFA were corrected for quantities of VFA measured in 
reagent blank tubes analyzed concurrently. 
Statistical Analysis 
 Statistical analyses were conducted utilizing the Proc Mixed procedure of SAS 
(version 9.1; SAS Institute Inc., Cary, NC).  The data were analyzed as a randomized 
complete block design, with period as a random effect. Effects of diet, week, and the 
interaction of diet and week were included in the model as fixed effects.  Baseline calves 
were not included in the analysis, but means and standard errors are shown for 
comparison.  Significant differences were declared at P < 0.05, and trends toward 
significant effects were noted at P <0.10.  
 
Results and Discussion 
VFA Concentrations and Profiles 
 Concentrations of VFA in rumen contents did not differ significantly between 
treatments (Table 3.1). The treatment × week interaction approached significance for 
concentrations of propionate and butyrate.  Concentrations of these VFA were higher for 
PSY calves in wk 1, but higher in CON calves during wk 2. Due to the small numbers of 
calves measured at each age, additional research would be necessary to determine 
whether these changes were repeatable and of significance to rumen development.  
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 The molar percentage of butyrate in the rumen was greater (P < 0.05) for PSY 
calves than for CON calves. An interaction of treatment × week occurred for rumen 
butyrate percentages (P < 0.04), with butyrate percentage being higher in PSY except in 
wk 2.  The greater relative abundance of butyrate could be of interest as butyrate is the 
VFA most responsible for stimulation of rumen epithelial development (Heinrichs, 2005).  
Although most milk replacer should have bypassed the rumen, small amounts can enter 
through incomplete closure of the reticular groove.  The presence of the fermentable 
psyllium for PSY calves may have led to greater butyrate formation.  
Total VFA concentrations (mMol/L) were low in the abomasum, and few 
significant differences in concentrations were observed between treatments (Table 3.2).  
A significant treatment × week interaction was noted for abomasal acetate percentage 
(moles per hundred moles of total VFA; P  < 0.02), with PSY being higher at wk 2 but 
CON being higher at wk 1, 3, and 4.  A significant treatment × week interaction was 
observed for abomasal propionate percentage ( P < 0.01), with PSY being higher at wk 1 
and 4 and CON being higher at wk 2 and 3.  Abomasal butyrate percentages tended (P < 
0.07) to be higher in the PSY calves than in CON calves. Furthermore, the percentage of 
isovalerate was greater (P < 0.03) for the PSY calves. 
 Concentrations of VFA also were low in jejunal contents (Table 3.3).  The PSY 
calves tended (P < 0.06) to exhibit higher jejunal acetate concentrations and 
concentrations decreased with age (Table 3.3). A tendency for an effect of week (P < 
0.06) was detected for jejunal butyrate concentrations, which increased from wk 1 to wk 
2 and then decreased during wk 2 to 4. The concentration of valerate was greater for PSY 
than for CON, and the treatment × week interaction was significant; valerate was greater 
  63 
 
for PSY calves for all weeks except wk 4.  The total concentration of VFA in the jejunum 
was very low compared with those in the rumen, but tended (P < 0.07) to be higher for 
calves fed PSY. This effect indicates that bacteria within the jejunum may have been able 
to ferment a portion of the psyllium during its passage through the small intestine.  
 The molar percentages of isobutyrate, butyrate, isovalerate, and valerate all 
exhibited a significant effect of week (P < 0.01), but no significant effect of treatment 
was observed. The small changes with age may reflect alterations in relative populations 
of microbial species within the small intestine but are of unknown importance. 
 In digesta from the proximal colon (Table 3.4), the PSY calves had higher 
concentrations of acetate (P < 0.001), propionate (P < 0.001), isobutyrate (P < 0.03), and 
butyrate (P <0.02). The PSY calves also tended (P < 0.06) to have higher concentrations 
of valerate but isovalerate did not differ. Therefore, total VFA concentrations also were 
significantly higher for the PSY calves compared to the CON calves (P < 0.001). A 
significant effect of week was also detected (P < 0.003) for individual and total VFA 
concentrations. The concentration of VFA generally increased with greater age of the 
calves.  Also, a significant treatment × week effect was noted for butyrate (P < 0.03), as 
differences between treatments became larger as the calves age grew older, possibly due 
to an increase in fermentation. 
 A tendency (P <0.10) was noted for the PSY calves to have a higher percentage of 
propionate in digesta from the proximal colon (Table 3.4). The CON calves had 
significantly higher (P <0.05) percentages of isovalerate in the proximal colon.  
 In digesta from the distal colon, PSY calves had higher concentrations of acetate 
(P < 0.01), propionate (P < 0.01), and isobutyrate (P < 0.05) than CON calves, and 
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tended (P < 0.09) to have higher concentrations of valerate (Table 3.5). The total 
concentration of VFA in the distal colon was higher for the PSY calves (P < 0.001) than 
for the CON calves, which would therefore indicate increased fermentation in the distal 
colon of calves fed the PSY treatment.  No significant differences were noted between 
CON and PSY treatments for molar percentages of VFA in the distal colon. 
 Overall, the predominant effect of psyllium inclusion in the milk replacer on VFA 
concentrations was in the lower gastrointestinal tract as indicated by the higher total VFA 
concentrations in the jejunum, proximal colon, and distal colon. Greater lower gut 
fermentation is logical because psyllium is a fiber that can be fermented by intestinal 
bacteria as seen in humans (Edwards et al., 1992) and monkeys (Costa et al., 1989b).  
Acetate concentrations were increased in the jejunum, proximal colon, and distal colon, 
similar to observations in cecal contents and feces of rats fed psyllium (Leng-Peschlow, 
1991).  Propionate concentrations were increased in the proximal colon and distal colon. 
In rats, fecal concentration of propionate was increased when psyllium was fed (Edwards 
et al., 1992).  
 The molar percentages of VFA in the jejunum or distal colon were not affected by 
inclusion of psyllium. However, there was a tendency in the proximal colon for the PSY 
calves to exhibit higher percentages of propionate, and for the CON calves to exhibit 
higher percentages of isovalerate. In monkeys no differences in the fecal VFA profile 
were observed when psyllium was fed (Costa et al., 1989b) or in a culture system 
utilizing the same monkeys (Costa et al., 1989a).  
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Bacterial Populations in the Digestive Tract 
 Ruminal bifidobacteria concentrations were significantly higher (P < 0.05) for the 
PSY calves than for the CON calves (Table 3.6). Counts did not differ between diets in 
jejunum or colon.  No differences were detected between CON and PSY treatments for 
Clostridium perfringens concentrations in the rumen, jejunum, or colon. Counts generally 
increased with age in the colon (P < 0.01) regardless of treatment. A weak tendency (P < 
0.11) was observed for the CON calves to have higher counts of E. coli present in the 
rumen. No other differences were noted between CON and PSY treatments.  Lactobacilli 
counts in the rumen were higher for the PSY calves (P < 0.02) when compared to the 
CON calves. There was also a significant effect of week (P < 0.001) observed for both 
rumen and jejunal lactobacilli concentrations, with counts higher in calves after wk 1.  
 Effects of psyllium inclusion on bacterial counts were minimal.  The inclusion of 
psyllium in the milk replacer increased rumen bifidobacteria and lactobacilli 
concentrations. These data potentially indicate an effect of psyllium inclusion as a 
prebiotic due to small amounts of milk replacer entering the rumen through incomplete 
closure of the reticular groove.  However, no significant differences in bifidobacteria and 
lactobacilli concentrations were observed in the jejunum or colon. 
 
Gastrointestinal Tract Size and Scale 
 A tendency was noted (P < 0.09) for the PSY calves to have heavier reticulo-
rumens (Table 3.7). Furthermore, a tendency for an effect of week (P < 0.07) was 
detected for reticulo-rumen length, as well as a significant (P < 0.03) effect of week on 
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reticulo-rumen weight. In addition, a tendency for an effect of week (P < 0.08) was noted 
for density (g/cm) of reticulo-rumen tissue.  
 No significant differences were noted between PSY and CON treatments for 
omasal growth parameters (Table 3.8).  There was a significant effect of week (P < 0.02) 
for abomasal length and for abomasal density per kg BW (P < 0.003; Table 3.9).  There 
was a tendency for an effect of week (P < 0.09) on g abomasum per kg BW, indicating 
that the abomasum decreased in size relative to the rest of the body as calves grew. 
 Calves fed PSY had heavier (P < 0.03) duodenal weights (Table 3.10). 
Furthermore, PSY calves had more duodenal tissue per kg BW (P < 0.02), and a tendency 
for more dense (g/cm) duodenal tissue (P < 0.06).  Also, PSY calves tended (P < 0.06) to 
exhibit a higher tissue density (g/cm) per kg BW.   
The CON calves had longer jejunums than the PSY calves (Table 3.11), although 
this difference did not achieve statistical significance (P < 0.09).  However, the PSY 
calves tended (P < 0.12) to have heavier jejunums, which resulted in greater (P < 0.056) 
mass of jejunum per unit BW. Furthermore, the PSY calves exhibited significantly (P < 
0.001) more dense jejunal tissue, which also carried through to significance (P < 0.001) 
for greater tissue density per unit of calf BW. However, the CON calves exhibited greater 
(P < 0.01) length of jejunal tissue per unit of calf BW. 
 The PSY calves had more dense (P < 0.04) ileal tissue than the CON calves 
(Table 3.12). As a result, the PSY calves tended (P < 0.08) to have greater density of ileal 
tissue per kg BW. 
 The effect of treatment was significant (P < 0.04) for colon weight with the PSY 
calves having heavier colons than CON calves (Table 3.13). This resulted in PSY calves 
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having greater grams of colon per kilogram calf BW (P < 0.01).  The PSY calves also 
tended (P < 0.06) to have greater density of  colon tissue than the CON calves, resulting 
in the PSY calves having more dense colon tissue per unit of calf BW (P < 0.04).   
The inclusion of psyllium in milk replacer did not increase lengths of the 
duodenum (P < 0.90), jejunum (P < 0.12), ileum (P < 0.51), or colon (P < 0.51). These 
data contrast with the effects observed in rats, where lengths of the small intestine (Leng-
Peschlow, 1991) and large intestine (Leng-Peschlow, 1991; Edwards et al., 1992) were 
increased when psyllium was included in the diet. However, tissue wet weights were 
increased for the PSY calves in the duodenum (P < 0.03), jejunum (P < 0.12), and colon 
(P < 0.04).  Rats fed psyllium also were reported to have greater small intestine 
(Schneeman and Richter, 1993) and colon (Edwards et al., 1992) weights.  The increased 
tissue density of duodenum (P < 0.06), jejunum (P < 0.01), ileum (P < 0.04), and colon 
(P < 0.06) for calves consuming psyllium was similar to the increased tissue density of 
small intestine and colon observed in rats (Leng-Peschlow, 1991).  
 
Conclusions 
 The increase in size and scale of the gastrointestinal tract could be of benefit to 
the neonatal dairy calf from a standpoint of potential greater absorptive capacities of the 
tissue, and greater tissue resistance to disease intrusion into the bloodstream. The 
inclusion of a fermentable fiber could also potentially “set-up” the path to allow more 
rapid gastrointestinal growth once calf starter ingestion begins. However, more 
gastrointestinal tissue may increase dietary nutrient requirements for maintenance of 
these highly metabolically active tissues. 
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 The lack of significant microbial changes in the gastrointestinal tract despite the 
increase in VFA could be due to subtle differences or a small sample size with an assay 
with a larger margin of error compared to other assays utilized in this study. This is an 
area that merits further research with a larger sample size to determine potential effects of 
inclusion of psyllium in milk replacers on microbial populations of the gastrointestinal 
system of the neonatal dairy calf. 
 The lack of differences in ADG for calves fed PSY (see Chapter 2) could be 
attributed to the fact that these calves were limit fed and were not fed a more biologically 
normal diet to allow for maximal ADG and feed intakes. A future trial should be done 
with the use of calf starter, as that is where there could be more benefit due to potential 
synergisms.  
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Table 3.1.  Least squares means and associated standard errors for weekly concentrations (mMol/L) and molar percentages of VFA in ruminal digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
 Acetate                     
  concentration 21.94 3.32 22.73 32.03 6.11 40.11 36.11 6.11 31.43 44.02 6.11 40.47 32.63 5.31 33.68 36.20 3.08 0.55 0.26 0.23 
  percentage 73.34 3.36 68.94
c
 61.93
d
 3.56 58.34
e
 68.73
f
 3.56 70.65 71.26 3.56 71.87 68.11 3.14 67.45 67.51 2.09 0.98 0.09 0.07 
                     
Propionate                     
  concentration 4.51 1.16 7.09
a
 13.22
b
 2.45 18.24
a
 11.77
b
 2.45 8.93 11.91 2.45 11.27 9.56 2.12 11.38 11.61 1.18 0.89 0.17 0.09 
  percentage 15.64 3.42 22.18 24.8 2.65 26.69 24.58 2.65 20.65 19.98 2.65 19.52 21.07 2.45 22.26 22.61 1.99 0.8 0.03 0.62 
                     
Isobutyrate                     
  concentration 0.50 0.18 0.51 1.52 0.40 1.47 1.03 0.40 0.84 1.11 0.40 1.15 1.03 0.34 0.99 1.17 0.19 0.51 0.91 0.32 
  percentage 1.55 0.64 1.56 2.7 0.38 1.79 1.73 0.38 1.9 1.77 0.38 1.97 2.25 0.33 2.11 1.81 0.19 0.25 0.67 0.36 
                     
Butyrate                     
  concentration 1.01 0.2 0.66
a
 2.51
b
 0.53 2.00
c
 0.76
d
 0.53 1.05 1.82 0.53 1.44 1.35 0.46 1.29 1.61 0.26 0.39 0.98 0.06 
  percentage 3.60 0.11 2.14
g
 4.60
h
 0.69 2.56 1.52 0.69 2.49 3.03 0.69 2.46 3.71 0.63 2.41 3.21 0.49 0.05 0.12 0.04 
                     
Isovalerate                     
  concentration 0.36 0.09 0.41 1.9 0.56 1.83 1.11 0.56 0.8 1.16 0.56 1.21 1.03 0.49 1.30 1.06 0.27 0.55 0.84 0.27 
  percentage 1.29 0.31 1.27 3.33 0.59 2.06 1.80 0.59 1.80 1.87 0.59 2.06 2.69 0.51 1.80 2.42 0.29 0.14 0.71 0.25 
                     
Valerate                     
  concentration 1.56 0.64 1.36 1.57 2.8 9.93 1.10 2.8 1.26 1.41 2.8 1.21 1.07 2.43 3.44 1.29 1.36 0.27 0.34 0.30 
  percentage 5.41 2.22 4.22 2.95 1.99 8.89 1.96 1.99 2.83 2.41 1.99 2.12 2.36 1.72 4.52 2.41 1.05 0.17 0.44 0.33 
                     
Total VFA 
concentration 29.62 4.04 32.89 52.88 11.43 73.71 52.02 11.43 44.45 61.56 11.43 56.74 47.26 9.9 51.95 53.43 5.53 0.85 0.41 0.21 
                               
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for comparison but were not included in the statistical analyses. 
7
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  ii 
 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b
 Subcolumn means within row and week category with different superscripts differ ( P < 0.10). 
c,d
 Subcolumn means within row and week category with different superscripts differ ( P < 0.15). 
e,f
 Subcolumn means within row and week category with different superscripts differ ( P < 0.05). 
g,h
 Subcolumn means within row and week category with different superscripts differ ( P < 0.01). 
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Table 3.2.  Least squares means and associated standard errors for weekly concentrations (mMol/L) and molar percentages of VFA in abomasal digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Acetate                     
  concentration 0.45 0.10 5.17 8.03 1.78 8.53 2.37 1.78 2.78 2.85 1.78 3.11 3.61 1.54 4.89 4.21 0.86 0.58 0.14 0.11 
  percentage 64.02 3.62 79.34
a
 67.81
b
 3.18 71.78
c
 81.87
d
 3.18 79.64 79.47 3.18 80.40
e
 74.70
f
 2.75 77.8 75.96 1.51 0.40 0.33 0.02 
                     
Propionate                     
  concentration 0.02 0.01 1.13 2.96 0.87 2.78 0.22 0.87 0.31 0.22 0.87 0.38 0.50 0.75 11.48 0.97 0.42 0.77 0.15 0.13 
  percentage 2.75 0.67 10.75
g
 18.51
h
 3.27 20.37 7.35 3.27 7.61
i
 6.40
j
 3.27 6.49 10.95 2.89 11.3 10.8 1.91 0.81 0.05 0.01 
                     
Isobutyrate                     
  concentration 0.01 0.01 0.14
k
 0.49
l
 0.10 0.26
m
 0.06
n
 0.10 0.07 0.07 0.10 0.08 0.16 0.08 0.14 0.19 0.05 0.42 0.09 0.07 
  percentage 2.46 1.15 2.87 3.75 0.56 1.9 2.06 0.56 1.95 1.97 0.56 2.39 2.10 0.49 2.27 2.47 0.31 0.59 0.06 0.69 
                     
Butyrate                     
  concentration 0.21 0.1 0.15 0.63 0.16 0.30 0.06 0.16 0.07 0.08 0.16 0.10 0.18 0.14 0.15 0.239 0.08 0.46 0.27 0.22 
  percentage 25.4 4.09 2.44 4.00 0.67 2.14 2.07 0.67 2.12 2.37 0.67 2.12 3.9 0.58 2.2 3.08 0.32 0.07 0.27 0.38 
                     
Isovalerate                     
  concentration 0.01 0.01 0.07 0.52 0.13 0.27 0.03 0.13 0.03 0.07 0.13 0.06 0.08 0.11 0.11 0.18 0.06 0.46 0.25 0.11 
  percentage 2.08 1.69 1.31 3.46 0.53 1.79 1.16 0.53 1.04 1.92 0.53 1.07 1.94 0.46 1.30 2.12 0.26 0.03 0.25 0.11 
                     
Valerate                     
  concentration 0.03 0.01 0.14 0.17 0.07 0.27 0.15 0.07 0.22 0.26 0.07 0.25 0.30 0.07 0.22 0.02 0.05 0.92 0.17 0.35 
  percentage 4.16 0.78 3.12 2.32 1.75 1.89 5.36 1.75 7.51 7.73 1.75 7.53 5.08 1.64 5.01 5.12 1.43 0.90 0.00 0.12 
Total VFA 
Concentration 0.74 0.21 6.81
o
 12.81
p
 2.93 12.41
q
 2.89
r
 2.93 3.49 3.57 2.93 3.99 4.82 2.54 6.67 6.02 1.42 0.75 0.14 0.10 
 
                
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction 
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  ii 
 
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b,c,d,k,l,m,n,o,p,q,r
 Subcolumn means within row and week category with different superscripts differ ( P < 0.05). 
e,f 
Subcolumn means within row and week category with different superscripts differ ( P < 0.17). 
g,h
 Subcolumn means within row and week category with different superscripts differ ( P < 0.10). 
i,j
 Subcolumn means within row and week category with different superscripts differ ( P < 0.001). 
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 Table 3.3.  Least squares means and associated standard errors for weekly concentrations (mmol/L) and molar percentages of VFA in jejunal digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Acetate                     
  concentration 2.85 1.50 1.13 1.95 0.26 0.94 1.09 0.26 1.22 1.80 0.26 0.94 0.79 0.22 1.06 1.41 0.12 0.06 0.02 0.21 
  percentage 53.61 1.56 69.05 65.26 3.53 61.68 56.47 3.53 63.25 65.24 3.53 59.64 64.07 3.15 63.4 62.76 2.22 0.76 0.10 0.32 
                     
Propionate                     
  concentration 0.34 0.21 0.07 0.20 0.05 0.13 0.14 0.05 0.10 0.14 0.05 0.10 0.06 0.04 0.10 0.13 0.03 0.28 0.39 0.26 
  percentage 5.58 0.34 4.66 6.77 1.29 6.92 6.41 1.29 5.37 4.96 1.29 5.58 5.52 1.16 5.63 5.92 0.83 0.72 0.60 0.62 
                     
Isobutyrate                     
  concentration 0.09 0.02 0.04 0.05 0.03 0.12 0.11 0.03 0.10 0.14 0.03 0.08 0.05 0.03 0.08 0.09 0.02 0.85 0.04 0.58 
  percentage 3.09 0.98 3.00 2.02 0.85 6.71 5.41 0.85 5.20 5.40 0.85 4.48 4.09 0.74 4.85 4.23 0.41 0.30 0.00 0.82 
                     
Butyrate                     
  concentration 0.28 0.19 0.07 0.11 0.04 0.13 0.15 0.04 0.10 0.11 0.04 0.04 0.02 0.04 0.09 0.10 0.02 0.69 0.06 0.89 
  percentage 4.52 0.40 4.44 3.73 1.19 6.80 6.67 1.19 5.07 4.15 1.19 2.67 1.77 1.06 4.75 4.08 0.73 0.38 0.00 0.98 
                     
Isovalerate                     
  concentration 0.06 0.02 0.01 0.03 0.05 0.01 0.09 0.05 0.05 0.07 0.05 0.28 0.21 0.04 0.09 0.09 0.03 0.77 <0.001 0.15 
  percentage 1.32 0.46 1.27 1.05 0.95 1.12 4.18 0.95 2.60 2.63 0.95 17.12 17.11 0.85 5.53 6.24 0.59 0.23 <0.001 0.19 
                     
Valerate                     
  concentration 1.89 1.14 0.28
a
 0.61
b
 0.07 0.25
c
 0.41
d
 0.07 0.36 0.48 0.07 0.18 0.09 0.06 0.27 0.40 0.03 0.01 0.00 0.02 
  percentage 32.07 2.21 17.61
e
 21.20
f
 1.60 16.80
g
 20.89
h
 1.60 18.53 17.66 1.60 10.50
i
 7.198
j
 1.39 15.86 16.74 0.80 0.44 <0.001 0.09 
                     
Total VFA 5.52 3.07 1.62 2.96 0.42 1.60 2.01 0.42 1.96 2.77 0.42 1.61 1.23 0.36 1.70 2.24 0.20 0.07 0.08 0.17 
                                          
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction        
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
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3 
CON=Control diet         
4 
PSY= Psyllium-supplemented diet         
a,b
 Subcolumn means within row and week category with different superscripts differ ( P <  0.002). 
c,d,g,h 
Subcolumn means within row and week category with different superscripts differ ( P <  0.10). 
e,f,i,j 
Subcolumn means within row and week category with different superscripts differ ( P <  0.15). 
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Table 3.4.  Least squares means and associated standard errors for weekly concentrations (mMol/L) and molar percentages of VFA in the proximal colon digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Acetate                     
  concentration 7.42 1.20 12.38 14.23 3.02 12.46 25.85 3.02 11.39 22.62 3.31 14.93 28.91 2.62 12.79 22.90 1.50 <.001 0.03 0.15 
  percentage 75.41 6.21 72.61 64.72 3.80 57.13 64.45 3.80 55.95 63.85 4.16 65.07 60.67 3.29 62.69 63.84 1.89 0.78 0.11 0.09 
                     
Propionate                     
  concentration 0.38 0.28 1.97 3.14 0.89 3.72 8.11 0.89 3.36 6.12 0.98 3.14 6.54 0.77 3.05 5.98 0.44 <.001 0.004 0.33 
  percentage 3.91 2.81 9.80 13.77 2.15 16.25 20.42 2.15 17.59 18.00 2.32 13.59 13.98 1.91 14.25 16.24 1.16 0.10 0.003 0.59 
                     
Isobutyrate                     
  concentration 0.19 0.10 0.10 0.21 0.09 0.17 0.28 0.09 0.20 0.18 0.10 0.25 0.60 0.08 0.18 0.29 0.03 0.03 0.01 0.15 
  percentage 3.08 1.77 0.50 0.89 0.25 0.70 0.68 0.25 1.19 0.64 0.31 1.12 1.45 0.22 0.84 0.91 0.13 0.67 0.03 0.37 
                     
Butyrate                     
  concentration 1.50 0.52 2.30 3.68 1.66 5.15 4.75 1.66 3.97 5.23 1.73 3.64
a
 8.78
b
 1.56 3.77 5.61 1.35 0.02 0.03 0.05 
  percentage 13.70 3.81 13.23 16.92 3.61 22.16
c
 11.56
d
 3.61 20.85 15.55 3.79 16.02 18.73 3.35 18.07 15.69 2.78 0.20 0.69 0.02 
                     
Isovalerate                     
  concentration 0.23 0.05 0.25 0.28 0.14 0.37 0.28 0.14 0.50
e
 0.17
f
 0.15 0.35
g
 0.83
h
 0.12 0.36 0.39 0.07 0.79 0.05 0.02 
  percentage 2.92 0.65 1.68 1.13 0.58 1.57 0.73 0.58 2.72 0.67 0.63 1.61 1.96 0.51 1.87 1.06 0.28 0.05 0.62 0.16 
                     
Valerate                     
  concentration 0.13 0.03 0.16 0.46 0.27 0.32 0.63 0.27 0.33 0.24 0.29 0.59 1.34 0.24 0.36 0.62 0.13 0.06 0.01 0.32 
  percentage 1.51 0.32 1.69 2.08 0.72 1.71 1.68 0.72 1.56 0.82 0.79 2.60 2.93 0.62 1.89 1.88 0.36 0.98 0.13 0.85 
                     
Total VFA 9.93 1.27 17.46 22.32 4.36 22.51 40.20 4.36 19.92 34.87 4.76 22.90 47.21 3.79 20.77 35.85 2.11 <.0001 0.003 0.12 
                                        
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction         
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2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b,c,d
 Subcolumn means within row and week category with different superscripts differ (P < 0.01). 
e,f 
Subcolumn means within row and week category with different superscripts differ (P < 0.13). 
g,h 
Subcolumn means within row and week category with different superscripts differ (P < 0.005). 
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Table 3.5.  Least squares means and associated standard errors for weekly concentrations (mmol/L) and molar percentages of VFA in distal colon digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overal diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Acetate                     
  
concentration 9.76 3.60 15.71 14.46 3.07 13.01 27.24 3.07 9.24 17.59 3.73 14.5 21.2 2.67 13.12 20.12 1.65 <0.01 0.18 0.12 
  percentage 70.25 8.57 67.66 61.65 5.15 52.11 59.87 5.15 47.2 53.96 6.07 59.84 56.29 4.59 56.7 57.94 3.31 0.71 0.07 0.36 
                     
Propionate                     
  
concentration 0.54 0.40 3.08 3.77 1.13 4.64 9.99 1.13 3.73 6.15 1.38 3.97 5.87 0.99 3.86 6.44 0.62 <0.01 0.02 0.22 
  percentage 5.20 4.18 67.66 61.65 5.15 52.11 59.87 5.15 47.20 53.96 6.07 59.84 56.29 4.59 16.56 17.56 1.61 0.71 0.07 0.36 
                     
Isobutyrate                     
  
concentration 0.10 0.07 0.17 0.23 0.09 0.25 0.38 0.09 0.24 0.33 0.11 0.35 0.58 0.07 0.25 0.38 0.04 0.05 0.03 0.75 
  percentage 0.74 0.42 0.65 0.87 0.37 0.82 0.84 0.37 1.35 1.16 0.46 1.59 1.95 0.32 1.10 1.21 0.19 0.70 0.03 0.89 
                     
Butyrate                     
  
concentration 2.53 0.86 3.44 4.25 2.52 7.24 6.22 2.52 5.22 7.25 2.73 4.19 8.35 2.39 5.02 6.52 2.15 0.18 0.25 0.33 
  percentage 21.92 5.86 17.16 18.73 4.49 27.30
a
 14.43
b
 4.49 25.92 22.47 5.00 17.58 20.68 4.19 21.99 19.08 3.57 0.21 0.30 0.07 
                     
Isovalerate                     
  
concentration 0.14 0.04 0.30 0.45 0.24 0.47 0.34 0.24 0.69 0.30 0.29 0.50 1.05 0.21 0.49 0.53 0.12 0.80 0.25 0.22 
  percentage 1.35 0.47 1.34 1.57 0.86 1.57 0.75 0.86 3.99 1.12 1.05 2.26 2.9 0.74 2.29 1.58 0.44 0.27 0.27 0.26 
                     
Valerate                     
  
concentration 0.09 0.03 0.01 0.54 0.33 0.18 0.74 0.33 0.27 0.28 0.4 0.62 1.06 0.29 0.27 0.65 0.2 0.1 0.21 0.83 
  percentage 0.68 0.16 0.09 1.9 1.01 0.62 1.63 1.01 1.34 0.82 1.2 2.45 3.82 0.89 1.13 2.04 0.61 0.18 0.05 0.67 
                     
7
8
 
 
  viii 
 
Total VFA 
13.00 2.93 22.63 23.62 4.53 25.7 44.84 4.53 19.4 31.8 5.13 24.13 33.63 4.17 22.96 33.47 3.4 <0.001 0.02 0.11 
                                       
1
 P-value.  T= effect of treatment, W = effect of week, T*W= treatment x week interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b 
Subcolumn means within row and week category with different superscripts differ ( P  < 0.01). 
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Table 3.6.  Least squares means and associated standard errors of bacteria concentrations
1
 in neonatal calf digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
3
 SE CON
4
 PSY
5
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen                     
  
Bifidobacteria 9.70 0.73 9.67 10.12 0.47 9.27 10.01 0.54 9.96 10.21 0.47 9.89 10.90 0.42 9.698 10.31 0.329 0.05 0.35 0.77 
  E. coli 9.63 0.28 10.36 9.70 0.60 9.85 9.25 0.60 10.34 9.57 0.60 10.33 9.65 0.52 10.22 9.542 0.289 0.11 0.83 1.00 
  Clostridium 
perfringens 9.14 0.35 8.93 9.62 0.31 9.01 8.36 0.31 9.08 8.91 0.31 8.68 8.96 0.27 8.925 8.961 0.152 0.87 0.29 0.21 
  Lactobacilli 6.76 0.78 5.46 6.39 0.48 9.85 11.26 0.83 9.44 10.71 0.83 7.94 9.10 0.42 8.173 9.365 0.35 0.02 <0.001 0.98 
                     
Jejunum                     
  
Bifidobacteria 8.47 0.36 5.91 8.18 0.88 5.75 4.94 0.99 6.48 7.23 0.88 5.84 5.68 0.81 5.996 6.507 0.674 0.30 0.07 0.16 
  E. coli 7.70 0.77 5.59 5.96 0.92 6.29 5.13 0.75 6.34 5.25 0.92 4.96 4.79 0.65 5.795 5.283 0.407 0.38 0.51 0.75 
  Clostridium 
perfringens 5.54 0.35 4.72
a
 6.77
b
 0.46 5.67 5.69 0.56 5.73
c
 4.68
d
 0.46 5.72 5.35 0.40 5.462 5.622 0.257 0.62 0.64 0.02 
  Lactobacilli 8.12 0.43 4.20 4.41 0.40 9.07 3.58 0.54 . 10.26 0.54 4.73 4.74 0.35 . 5.747 0.297 0.19 <0.001 0.39 
                     
Colon                      
  
Bifidobacteria 10.38 0.41 10.34 10.89 0.46 10.10 10.63 0.56 11.26 11.35 0.46 10.66 10.44 0.40 10.59 10.83 0.238 0.49 0.26 0.80 
  E. coli 9.90 0.25 9.19 9.20 0.63 8.79 8.57 0.63 8.71 9.21 0.63 8.34 8.92 0.55 8.756 8.978 0.334 0.62 0.78 0.90 
  Clostridium 
perfringens 8.55 0.33 7.62 8.10 0.61 7.93 7.75 0.61 9.49 9.68 0.61 9.19 9.48 0.55 8.557 8.754 0.414 0.58 0.003 0.92 
  Lactobacilli 8.66 0.51 7.79 7.71 0.95 10.18 11.37 1.41 10.92 11.80 1.41 9.12 9.69 0.95 9.503 10.14 0.804 0.39 0.03 0.91 
                                          
                      
1 
Data expressed as log10 CFU/g sample on a DM basis 
2
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction         
3
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
4 
CON=Control diet          
8
0
 
 
  x 
 
5 
PSY= Psyllium-supplemented diet         
a,b
 Subcolumn means within row and week category with different superscripts differ ( P < 0.005). 
c,d
 Subcolumn means within row and week category with different superscripts differ ( P < 0.12). 
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Table 3.7.  Least squares means and associated standard errors for weekly measurements of reticulo-rumen (RR). 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, cm 24.67 1.15 26.50 31.84 2.18 29.84 30.84 2.18 32.00 33.84 2.18 33.75 33.10 1.97 30.52 32.40 1.47 0.15 0.07 0.39 
                     
Weight, g 182.6 6.4 183.5 238.5 25.3 248.9 210.8 25.3 242.8 312.7 25.3 255.2 280.2 22.4 232.6 260.6 15.0 0.09 0.03 0.13 
                     
G RR per kg 
BW 3.73 0.10 4.14 5.17 0.40 5.39 4.82 0.40 4.87 5.80 0.40 4.74 5.12 0.35 4.79 5.23 0.20 0.12 0.39 0.20 
                     
Density 
(g/cm) 7.46 0.32 6.92 7.48 0.47 8.28
c
 6.81
d
 0.47 7.61
e
 9.18
f
 0.47 7.61
g
 8.46
h
 0.41 7.61 7.98 0.23 0.25 0.08 0.03 
                     
cm RR per kg 
BW 0.49 0.04 0.60 0.69 0.04 0.65 0.70 0.04 0.64 0.63 0.04 0.63 0.61 0.04 0.63 0.66 0.02 0.31 0.49 0.50 
                     
(g/cm)/ kg 
BW 0.15 0.01 0.16 0.16 0.01 0.18 0.16 0.01 0.15 0.17 0.01 0.14 0.16 0.01 0.16 0.16 0.00 0.59 0.18 0.15 
                     
* Baseline values are shown for informational purposes and are not included in the statistical analyses 
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet         
4 
PSY= Psyllium-supplemented diet         
c,d,e,f
 Subcolumn means within row and week category with different superscripts differ ( P < 0.05). 
g,h
 Subcolumn means within row and week category with different superscripts differ ( P = 0.14). 
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Table 3.8.  Least squares means and associated standard errors of weekly omasal (OM) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, cm 6.83 0.21 6.58 6.67 0.59 9.17 6.83 0.59 7.33 7.33 0.59 7.13 7.15 0.51 7.552 6.996 0.283 0.18 0.16 0.13 
                     
Weight, g 68.47 3.85 59.47 63.6 8.64 83.27 66.93 8.64 80.83 71.1 8.64 78.48 75.52 7.48 75.51 69.29 4.182 0.3 0.25 0.67 
                     
g OM per kg 
BW 1.4 0.07 1.37 1.38 0.14 1.81 1.53 0.14 1.64 1.35 0.14 1.44 1.37 0.12 1.568 1.407 0.068 0.11 0.16 0.61 
                     
Density (g/cm) 10.03 0.52 9.05 9.42 1.11 9.47 9.74 1.11 11.08 9.74 1.11 10.96 10.62 0.96 10.14 9.881 0.538 0.74 0.43 0.86 
                     
Cm OM per 
kg BW 0.14 0 0.15 0.15 0.01 0.2 0.16 0.01 0.15 0.14 0.01 0.13 0.13 0.01 0.158 0.144 0.006 0.11 0.01 0.28 
                     
(g/cm)/ kg BW 0.21 0.01 0.21 0.21 0.02 0.21 0.22 0.02 0.23 0.19 0.02 0.2 0.19 0.02 0.211 0.202 0.011 0.53 0.86 0.64 
                     
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet        
4 
PSY= Psyllium-supplemented diet        
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Table 3.9.  Least squares means and associated standard errors of weekly abomasal (AB) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, cm 35.3 4.2 31.2 36.7 1.7 28.8 29.7 1.7 35.7 33.2 1.7 32.9 34.6 1.4 32.1 33.5 0.8 0.23 0.02 0.15 
                     
Weight, g 277.6 11.6 224.1 257.2 21.4 254.7 231.0 21.4 239.8 254.7 21.4 240.5 263.6 18.9 239.8 251.6 12.5 0.39 0.92 0.50 
                     
g AB per kg 
BW 5.58 0.25 5.07 5.55 0.36 5.53 5.26 0.36 4.81 4.74 0.36 4.46 4.86 0.31 4.97 5.10 0.17 0.59 0.09 0.65 
                     
Density (g/cm) 7.28 0.39 7.21 7.05 0.69 8.83 7.93 0.69 7.65 6.76 0.69 7.36 7.75 0.61 7.54 7.60 0.40 0.89 0.23 0.54 
                     
Cm AB per kg 
BW 0.72 0.12 0.72 0.81 0.05 0.63 0.69 0.05 0.72 0.63 0.05 0.61 0.63 0.04 0.67 0.69 0.02 0.65 0.05 0.35 
                     
(g/cm)/ kg BW 0.16 0.01 0.16 0.15 0.01 0.19 0.18 0.01 0.14 0.14 0.01 0.14 0.15 0.01 0.16 0.15 0.01 0.94 0.004 0.49 
                      
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet         
4 
PSY= Psyllium-supplemented diet         
8
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Table 3.10.  Least squares means and associated standard errors of duodenal (DU) growth 
parameters. 
 Overall diet means P
1
 
Variable CON
2
 PSY
3
 SE T W T*W 
       
Length, cm 30.2 30.6 2.1 0.89 0.15 0.45 
       
Weight, g 50.6 67.9 8.2 0.03 0.83 0.83 
       
g DU per kg BW 1.05 1.38 0.16 0.02 0.73 0.78 
       
Density (g/cm) 1.80 2.22 0.28 0.06 0.25 0.94 
       
Cm DU per kg BW 0.64 0.63 0.05 0.86 0.03 0.64 
       
(g/cm)/ kg BW 0.04 0.05 0.01 0.06 0.27 0.74 
              
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week Interaction 
2 
CON=Control diet. 
3 
PSY= Psyllium-supplemented diet 
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Table 3.11.  Least squares means and associated standard errors of weekly jejunal (JE) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variabl
e 
Base
line
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length
, cm 
1633
.6 65.4 
1573.
8 
1756.
5 
126.
0 
1683.
5 
1399.
0 126.0 
1796.
8 
1448.
1 
126.
0 
1731.
5 
1573.
8 
109.
1 
1686.
4 
1542.
1 
61.
0 0.09 0.76 0.19 
                     
Weight
, g 
1028
.9 99.1 893.3 955.1 
102.
3 936.0 968.4 102.3 900.8 
1128.
4 
102.
3 953.8 
1081.
6 88.6 921.0 
1033.
4 
49.
5 0.12 0.72 0.78 
                     
g JE 
per kg 
BW 
19.6
5 0.42 20.28 20.75 1.39 20.36 22.30 1.39 18.18 21.23 1.39 17.55 19.77 1.20 19.09 21.01 
0.6
7 0.06 0.22 0.82 
                     
Densit
y 
(g/cm) 0.65 0.09 0.57 0.54 0.04 0.55
a
 0.69
b
 0.04 0.49
c
 0.78
d
 0.04 0.55
e
 0.69
f
 0.03 0.54 0.68 
0.0
2 
<0.00
1 0.10 
0.00
4 
                     
Cm JE 
per kg 
BW 
32.4
0 3.02 36.02 38.45 1.66 
36.70
g
 
32.24
h
 1.66 36.24
i
 27.35
j
 1.66 
31.85
k
 28.66
j
 1.44 35.20 31.67 
0.8
1 0.01 0.001 0.03 
                     
(g/cm)/ 
kg BW 0.01 0.00 0.01 0.01 0.00 0.01
m
 0.02
n
 0.00 0.01
o
 0.02
p
 0.00 0.01
q
 0.01
r
 0.00 0.01 0.01 
0.0
0 
<0.00
1 0.02 0.01 
                                     
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet         
4 
PSY= Psyllium-supplemented diet         
a, b, c , d ,I,j,m,n,o,p,q,r,e,f
 Subcolumn means within row and week category with different superscripts differ ( P < 0.01). 
g,h
 Subcolumn means within row and week category with different superscripts differ ( P < 0.10). 
k,l
 Subcolumn means within row and week category with different superscripts differ ( P < 0.15). 
8
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Table 3.12.  Least squares means and associated standard errors of ileum (IE) growth 
parameters. 
 Overall diet means P
1
 
Variable CON
2
 PSY
3
 SE T W T*W 
       
Length, cm 58.9 70.1 11.9 0.51 0.45 0.99 
       
Weight, g 52.5 67.5 9.4 0.27 0.46 0.48 
       
g IE per kg BW 1.12 1.39 0.21 0.37 0.70 0.43 
       
Density (g/cm) 0.92 1.12 0.12 0.08 0.09 0.40 
       
Cm IE per kg BW 1.26 1.47 0.28 0.59 0.38 0.99 
       
(g/cm)/ kg BW 0.02 0.02 0.00 0.15 0.23 0.30 
             
1
 P-value.  T= effect of treatment, W = effect of week, T*W= treatment x week interaction 
2 
CON=Control diet 
3 
PSY= Psyllium-supplemented diet 
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Table 3.13.  Least squares means and associated standard errors of colon (COL) 
growth parameters. 
 Overall diet means P
1
 
Variable CON
2
 PSY
3
 SE T W T*W 
       
Length, cm 191.3 184.1 12.6 0.51 0.16 0.67 
       
Weight, g 407.9 467.3 18.6 0.04 0.84 0.49 
       
g COL per kg BW 8.43 9.45 0.45 0.01 0.008 0.21 
       
Density (g/cm) 2.19 2.58 0.21 0.06 0.21 0.93 
       
Cm COL per kg BW 3.98 3.74 0.22 0.41 0.08 0.77 
       
(g/cm)/ kg BW 0.05 0.05 0.00 0.04 0.01 0.61 
             
1
 P-value.  T= effect of treatment, W = effect of week, T*W = treatment x week 
interaction 
2 
CON=Control diet 
3 
PSY= Psyllium-supplemented diet 
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CHAPTER 4 
Effects of inclusion of psyllium in milk replacer on ion transport and 
histomorphological measures in the gastrointestinal tract of neonatal dairy calves 
 
Introduction 
Optimal health and growth of dairy calves is an important determinant of dairy 
farm profitability.  The majority (56.5%) of unweaned heifer deaths can be attributed to 
scours (diarrhea) or other digestive challenges (National Animal Health Monitoring 
System, 2007).  Therefore, efforts to improve gastrointestinal tract function and disease 
resistance should lead to improved welfare and growth performance.  Psyllium has been 
studied in many species for its potential effects on digestive function, rate of passage, 
nutrient absorption, and intestinal morphology.  A predominant role of dietary fiber, 
particularly viscous fermentable fibers, in the stomach and small intestine is to limit the 
rate of release of nutrients by increasing the viscosity of the digesta, thereby reducing the 
rate of nutrient transport to the epithelium (Morris, 2001).  As a viscous fiber, psyllium 
would be expected to slow the rate of glucose absorption. For example, glucose 
absorption decreased in type 2 diabetic patients when psyllium was consumed (Sierra et 
al.2002).  Improvement in glucose tolerance from consumption of viscous fiber is 
thought to be more likely due to slower absorption of carbohydrate rather than decreased 
absorption (Sierra et al., 2002).  It could be postulated, therefore, that changes in release 
of absorbable nutrients in the intestine might alter expression or function of nutrient 
transporters.  
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 As a fermentable fiber, psyllium would be expected to favor intestinal anaerobic 
bacteria with the capacity to ferment it.  Increased fermentation in the lower tract results 
in greater concentrations of VFA, which in turn increase mass of the gastrointestinal tract 
in other species (Leng-Peschlow, 1991; Edwards et al. 1992; Schneeman and Richter, 
1993; Edwards et al. 2003).  The VFA also have been shown to stimulate intestinal villus 
length and crypt depth (Kuzmuk et al., 2005) and increase rates of nutrient transport in 
the small intestine (Tappenden et al., 2003). 
Butyrate is the VFA most responsible for stimulation of rumen epithelial 
development and differentiation, with propionate being the second most stimulatory 
(Heinrichs, 2005). Therefore, an increase in production of VFA as a result of inclusion of 
psyllium in milk replacer could potentially stimulate ruminal papillae development, as 
well as villi development throughout the lower gastrointestinal tract. Minimal changes in 
ruminal papillae growth and development would be expected when psyllium is 
supplemented to milk replacer, however, because of the esophageal groove closure that 
allows most milk replacer to bypass the rumen.  However, if there is greater fermentation 
and production of VFA in the lower gastrointestinal tract, VFA that enter the bloodstream 
could impact rumen papillae growth and development via systemic effects.  
In newborn calves less than 3 d old, the papillae of the rumen are partially 
developed.  However, if the calf receives a diet of only milk or milk replacer, the papillae 
will show regressive changes, both in length and shape (Tamate et al., 1962).  This 
regression of growth is theorized to result from the lack of VFA reaching the rumen from 
the milk diet, because of esophageal groove closure.  Rumen development present in 
newborn calves can be attributed to VFA in the maternal blood, which supplies the fetal 
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rumen tissue with VFA that stimulate papillae growth and development (Tamate et al., 
1962).  In a similar manner, therefore, VFA present in the calf’s blood from lower 
gastrointestinal fermentation and absorption could impact ruminal papillae development.  
The potential impact of psyllium on nutrient transport and gastrointestinal 
histomorphology in young dairy calves is not known.  My hypothesis was that psyllium 
would slow the rate of glucose and amino acid availability in the intestine, and as a result 
there would be alterations in rates of nutrient transport that could be measured in vitro.  
Furthermore, VFA from fermentation of psyllium in the lower gut would lead to 
enhanced villus size and crypt depth and to greater rates of nutrient transport throughout 
the digestive tract, which in turn might improve digestive function and gut health.  The 
purpose of this portion of the study, therefore, was to determine the effects of inclusion of 
psyllium in milk replacers on ion transport measures and histomorphological 
development in the gastrointestinal tract of neonatal dairy calves. 
 
Materials and Methods 
Animal Care 
 All procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee (protocol number 04083).   
 The study was conducted during two periods, the first (May 2004) using 12 calves 
and the second (June 2004) using 22 calves.  Male Holstein calves were purchased from 
Stone Ridge Dairy (Belleflower, IL) at less than 36 h of age.  
 At the beginning of the trial period, daily late-afternoon trips were made to Stone 
Ridge Dairy to select and purchase calves.  At Stone Ridge Dairy, all male Holstein 
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calves less than 36 h of age in the calf pack were evaluated for potential purchase by trial 
personnel.  The evaluation included body temperature, heart and lung auscultation, 
hydration status, mobility, navel status, and overall thriftiness. Also, the calves must have 
received at least one feeding of colostrum by Stone Ridge personnel. Calves deemed 
satisfactory were then transported to the University of Illinois Dairy Nutrition Field 
Laboratory.   
 Upon arrival, each calf received an eartag in the left ear for identification 
purposes.  Calves were then measured for withers height, body length, heart girth 
circumference, and body weight.  Ear notches were taken from each calf and placed in 
formalin for determination of persistently infected bovine viral diarrhea (PI-BVD) status.  
Each calf was vaccinated against infectious bovine rhinotracheitis virus and 
parainfluenza-3 intranasally (2 ml of TSV-2; Pfizer Animal Health, Exton, PA). In 
addition, calves received 15 mL of Quatracon-2X™ Antiserum (Boehringer Ingleheim 
Vetmedica, Inc.; St. Joseph, MO) subcutaneously in the neck.  Each calf also received 2 
mL of Excenel (Pfizer Animal Health; Exton, PA) subcutaneously in the neck.for the first 
3 d of the study.   After entry injections, the calves were moved to southward-facing 
individual calf hutches (Calf-Tel; Hampel Corp., Germantown, WI) on 15 to 20 cm of 
crushed limestone located on the south side of the Dairy Nutrition Field Laboratory.  No 
bedding was used, to minimize ingestion of bedding material that might confound 
treatment inferences. 
Assignment to Treatments 
 Calves were blocked by pairs based upon birth date, body weight, and total 
protein score in pairs and then randomly assigned within pair to each of the dietary 
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treatments.  These pairs of calves were then randomly assigned to harvest week.  Of the 
34 calves assigned to treatments, 1 calf died at 2 d of age.  Necropsy results (University 
of Illinois College of Veterinary Medicine, Urbana, IL) indicated that the cause of 
mortality was likely related to birth trauma.  All other calves completed the trial in good 
health.  
Feeding 
 On the night of arrival, each calf was offered colostrum for ad libitum intake.  On 
the morning following arrival, each calf again was offered colostrum.  Treatment 
feedings were administered at 0600 and 1800 h.  Calves were fed milk replacers 
reconstituted to 12.5% dry matter at a rate of 12% of BW daily, adjusted weekly as calves 
grew.  Milk replacers (Land O’Lakes Animal Milk Products Co.; Arden Hills, MN) with 
or without a 1.1% inclusion of psyllium were formulated to contain 22% protein and 20% 
fat, and contained only milk proteins.  Neither milk replacer contained growth-promoting 
antibiotics. Water was available to calves for ad libitum consumption, with fresh warm 
water provided twice daily after each milk replacer feeding. No other feeds were offered. 
Health Monitoring 
 Calves were observed at least twice daily for general health, including appearance 
(alertness), appetite (ability to consume feed), and fecal scores.  Fecal scores were 
recorded daily, using the following guidelines:  1 = dry, hard; 2 = soft, formed; 3 = 
pudding-like; 4 = mix of liquids with some solids; and 5 = liquid.  If the calf’s hydration 
status was low (skin tenting evident), 500 mL Lactated Ringers Solution (Abbott 
Laboratories; Abbott Park, IL) was administered subcutaneously.   If a calf appeared 
unhealthy, 3 mL of Excenel (Pfizer, Exton, PA) was administered subcutaneously for a 
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period of 3 d.  If body temperature was over 39° C, 1 mL of Banamine (Schering-Plough 
Animal Health; Union, NJ) was administered subcutaneously. Calves received a booster 
of TSV-2 at 2 wk of age.  
Calf Harvest Procedure 
 Pairs of calves were harvested for analysis weekly.  For period 1, 2 calves were 
euthanized after arrival before experimental treatments began (week zero) for baseline 
measurements.  For the remaining weeks, one pair of calves was euthanized weekly, with 
the exception of week 4.  In week 4 of period 1, 4 calves were euthanized. For period 2, 4 
baseline calves were euthanized at week zero, and 2 pairs were euthanized during weeks 
1, 2, and 3.  For week 4, 5 calves were harvested due to the 1 mortality. 
 Calves were transported to the University of Illinois College of Veterinary 
Medicine at 0630 h. Calves were not given their morning milk replacer prior to 
euthanasia. The harvest procedure consisted of the calf being administered Xylazine HCl 
intramuscularly (50 mg/mL; Fort Dodge Animal Health; Fort Dodge, IA).  Once the calf 
was sedated, it was euthanized with an intravenous overdose of sodium pentobarbital 
(Fatal Plus; Veterinary Laboratories Inc., Lenexa, KS) and then exsanguinated.   
 When the calf was declared dead, the veterinarian opened the body cavity. The 
gastrointestinal tract was ligated at the caudal esophagus and rectum and removed as 
rapidly as possible without damaging the tract.  To prevent movement of digesta between 
compartments, the different segments of the gastrointestinal tract were identified and 
ligated.  The gastrointestinal tract was then divided into three portions: the stomach 
portion consisting of rumen, reticulum, omasum, and abomasum; the small intestine, 
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consisting of duodenum, jejunum, and ileum; and the colon.  Each portion was processed 
by the respective team of personnel for tissue and digesta collection.   
Tissue Collection 
 Tissues for ion transport analysis were collected as soon as possible after 
euthanizing calves. Samples of dorsal rumen, medial jejunum, medial ileum, and medial 
colon were placed in oxygenated (95% O2:5% CO2) Krebs’ solution (120 mM MgCl2, 
120 mM CaCl2, 40 mM KH2PO4, 240mM K2HPO4 , 1.15 M NaCl2, and 260 mM 
NaHCO3) on ice. These samples were then transported to the laboratory for immediate 
analysis (within 30 min after euthanasia) of electrophysiological and ion transport 
measures. 
 For histomorphology, samples of dorsal rumen, caudal ventral blind sac of rumen, 
cranial ventral sac of rumen, medial jejunum, medial ileum, and medial colon were 
placed in glass scintillation vials containing 10% buffered formalin.  The locations for 
rumen sampling were those determined to give greatest accuracy in rumen development 
according to the methodology of Lesmeister et al. (2004).  Samples were transferred to 
70% ethanol solutions at a later date, as per procedures from Albin (2004).  
Ion Transport and Electrophysiological Response Studies 
 Ion transport was evaluated in segments of the rumen, jejunum, ileum, and colon. 
Modified Ussing chambers were used according to methods described by Kles and 
Tappenden (2002).  Briefly, tissue segments were mounted in modified Ussing chambers 
(Physiologic Instruments; San Diego, CA), exposing 0.5 cm
2
 of mucosa and serosa.  The 
tissue segments were bathed in oxygenated modified Krebs’ solution that was maintained 
at 37°C with a circulating water bath (Fisher Scientific).  Basal short-circuit current (Isc; 
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indicator of non-specific active ion transport), resistance (R; intestinal barrier function), 
and potential difference (Pdo; total ion transport) were established and measured during 
an initial stabilization period of less than 30 min.  The Isc was calculated according to 
Ohm's law, using I = V/R, where I is the current in amperes, V is the electromotive force 
in volts, and R is resistance in ohms.  
 Sodium-dependent glucose transport was measured by changes in short-circuit 
current induced by addition of 10 mM D-glucose to the mucosal medium. The modified 
Ussing chambers were connected to dual-channel voltage clamps (VCC MC2, 
Physiologic Instruments)  connected with data acquisition software (Acquire & Analyze; 
Physiological Instruments, San Diego, CA) to allow real-time data collection.  Peak Isc 
values (point of maximal change) were measured after each nutrient was added, and the 
difference between basal levels (measured prior to each nutrient addition) and peak 
measure was calculated. 
   Transport of glycylsarcosine, a synthetic dipeptide with methylated peptide bond 
for increased stability, was measured by addition of glycylsarcosine (to a final dilution of 
10 mM) to the mucosal Ussing chamber, in the same manner as described for 
measurement of glucose transport.  Amino acid transport (L-glutamine, L-proline, L-
arginine, and L-threonine) was measured in the same way as described for glucose 
transport.   Each amino acid was added to the mucosal side of the Ussing chambers to a 
final concentration of 10 mM.   
Histomorphology 
 The formalin-fixed rumen and intestinal samples were embedded in paraffin, 
sliced to approximately 5-μm thickness and stained with hematoxylin and eosin 
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(University of Illinois Clinical Pathology Laboratory, Urbana, IL). Measurements of 
papillae length, mid-papillae width, and papillae density were made for the dorsal rumen, 
caudal ventral blind sac of rumen, and cranial ventral sac of rumen. Villus width, mid-
villus height, and crypt depth were measured in samples from the medial jejunum and 
medial ileum. Crypt depths were measured in the medial colon.  Papillae density was 
recorded as the number of papillae per millimeter of serosal length.  All 
histomorphological measurements were made by using a Nikon Optiphot-2 microscope 
(Nikon; Melville, NY) and Image-Pro Express software (Version 4.5; Media Cybernetics, 
Inc., Silver Springs, MD).  To determine average measurements, 8 to 10 papillae, villi, or 
crypts were measured.  Mucosal surface area was estimated as (villus height × mid-villus 
width × villus density).  The technician was blinded to nutritional treatment and age of 
the calf. 
Statistical Analysis 
 Statistical analyses were conducted utilizing the Proc Mixed procedure of SAS 
(SAS version 9.1; SAS Institute Inc.; Cary, NC).  The data were analyzed as a 
randomized complete block design, with period as a random effect. Effects of diet, week, 
and the interaction of diet and week were included in the model as fixed effects.  Baseline 
calves were not included in the analysis, but means and standard errors are shown for 
comparison. Significant differences were declared at P < 0.05, and trends toward 
significant effects were noted at P < 0.15. 
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Results and Discussion 
Electrophysiological and Transport Measurements 
 No significant differences were observed for Isc values between diets in any of the 
gastrointestinal tract locations (Table 4.1).  However, a significant treatment × week 
interaction (P < 0.03) was noted in the rumen with PSY being higher than CON at wk 1.  
The Isc values in the ileum tended (P = 0.12) to be lower for PSY calves.  Higher Isc 
values (increased short circuit current) would indicate greater ion secretion and active 
transport. Thus, the possibility exists that psyllium supplementation altered ion secretion 
and active transport levels at least early in life, although this should be confirmed with 
additional research. 
 No significant differences between treatments were observed for resistance values 
(R) in the gastrointestinal tract locations measured (Table 4.2).  Increased R values 
generally reflect greater barrier function of the gastrointestinal tissue.  The lack of 
differences indicates that psyllium supplementation had no major effect on gut barrier 
function.  Means were greater during the treatment period than in baseline calves 
indicating an improvement in barrier function as calves grew, although the effect of week 
within the treatment period was not significant. 
 No significant differences between treatments were observed for Pdo values in 
any of the gastrointestinal tract locations (Table 4.3).  However, a significant interaction 
of treatment and week was detected for rumen tissue, in which the PSY treatment was 
significantly greater at wk 1 (P < 0.01).  Greater Pdo values indicate greater total ion 
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transport, which means that psyllium may have increased total ion transport in the rumen 
during early life but had little difference thereafter. 
Diet significantly affected the change in short circuit current induced by addition 
of  10 mM glucose (glucose) observed with CON calves exhibiting greater (P < 0.01) 
glucose transport than PSY calves in rumen, ileum, and colon (Table 4.4).  In addition, 
the treatment × week interaction was significant for rumen and colon, in which 
differences between diets were largest for calves measured at wk 1.  These data may be 
indicative of psyllium slowing the rate of glucose absorption, but not necessarily the 
quantity of glucose absorption. These data may support the blood glucose data reported in 
Chapter 2, in which higher blood glucose concentrations were observed pre-prandially for 
calves in the PSY treatment. Specifically, a slower rate of glucose absorption into the 
bloodstream could lead to less marked changes in insulin secretion to dispose of the 
glucose. However, the reduced rates of glucose transport for calves in the PSY treatment 
contradict research in other monogastric species. For example, in rats undergoing total 
parenteral nutrition, mucosal glucose uptake was increased when VFA were 
supplemented (Tappenden et al., 2003).  
 There were no significant differences between CON and PSY treatments for 
change in short circuit current induced by addition of 10 mM glutamine (glutamine; 
Table 4.5). However, a significant treatment × week interaction was noted in the ileum; at 
wk 2 values for the CON treatment were significantly higher (P < 0.05), whereas a 
tendency was noted at wk 3 for the PSY treatment to be higher (P < 0.10).  
 No effect of treatment was detected for change in short circuit current induced by 
addition of 10 mM glycylsarcosine  (glycylsarcosine) among gastrointestinal tract 
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locations (Table 4.6). The effect of week was significant for rumen (data not shown) in 
which means were higher for wk 2. 
 No effect of treatment was noted for change in short circuit current induced by 
addition of 10 mM proline ( proline) in any of the gastrointestinal tract locations (Table 
4.7).  A tendency for an effect of week was noted in the rumen (P < 0.09) with means 
being elevated at wk 2 and 3 compared to wk 1 and 4.  
No significant effects of treatment were noted for change in short circuit current 
induced by addition of 10 mM arginine (arginine) transport in any gastrointestinal tract 
location (Table 4.8). However, a significant (P < 0.003) treatment × week interaction was 
noted in the rumen, with PSY being higher at wk 1 (P < 0.05) and CON being higher at 
wk 2 (P < 0.001). Furthermore, a significant effect of week (P < 0.004) was noted in the 
rumen, with wk 4 means being lower than wk 1, 2, and 3.  The biological significance 
and implications are unclear.  
 Although no significant effects of treatment were observed for change in short 
circuit current induced by addition of 10 mM threonine (threonine transport; Table 4.9), 
a significant treatment × week interaction was noted in the rumen (P < 0.001). At wk 1, 
the PSY treatment exhibited significantly greater (P < 0.01) threonine transport when 
compared to the CON treatment.  
 Overall, few significant differences were noted between treatments for 
electrophysiological and ion transport measures; changes were only noted for Isc  and Pdo 
values in the rumen at wk 1 (with calves fed PSY being higher), in threonine and arginine 
transport in the rumen at wk 1 (PSY calves higher), and in glucose transport in the rumen, 
ileum, and colon ( P < 0.01), with the CON treatment exhibiting greater rates of glucose 
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transport. These latter data potentially indicate an adaptation at the cellular level for 
glucose transport to be slower when psyllium is included in the diet. However, this result 
does not agree with expectations based on previous research and the mechanism 
responsible is not known.  The VFA, and most specifically butyrate, are responsible for 
rumen epithelial growth and development (Heinrichs, 2005). Furthermore, physiological 
concentrations of butyrate have been shown to upregulate expression of key enterocyte-
associated nutrient transporters (Tappenden et al., 2003). Therefore, it is logical that the 
increased production of VFA from inclusion of psyllium in milk replacer (see Chapter 3) 
would have increased absorptive rates of glucose and possibly other substrates tested as 
observed in studies with other animal models (Tappenden et al., 2003), but this was not 
the case.  The significantly greater glucose transport observed in the rumen of the CON 
calves indicates that the effect was mediated systemically, because the milk replacer 
would have mostly bypassed the rumen. Further research is needed to determine the 
mechanism for these effects in neonatal dairy calves. 
Histomorphology of Gastrointestinal Tract 
No significant effect of treatment was observed for histomorphological measures 
in the rumen (Table 4.10).  However, a significant effect of week was noted (P < 0.01) 
for papillae length in the cranial ventral sac, being highest at wk 2.  Furthermore, a 
significant (P < 0.05) effect of week was noted for papillae length in the caudal ventral 
blind sac, with calves at wk 3 exhibiting the lowest values.  Papillae development in the 
rumen was minimal over the course of the study, which was expected because calves did 
not have access to starter (Davis and Drackley, 1998). In fact, papillae length decreased 
in the cranial ventral sac (P < 0.01) and caudal ventral blind sac (P < 0.05). 
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Measurements of villus height, villus width, and crypt depth did not differ in 
jejunum, regardless of treatment, age, or their interaction (Table 4.11).  In the colon 
(Table 4.12), dietary treatments did not affect crypt depth or width.  However, there was 
a tendency (P < 0.07) toward an effect of week for colon crypt depth, with depths 
decreasing for wk 1, 2, and 3 but increasing at wk 4.   
 The lack of many significant differences noted for histomorphological measures 
could be attributed to the lack of ingestion of dry feed, thereby minimizing microbial end 
products to enhance ruminal papillae growth and development. Perhaps the amount of 
psyllium included in the milk replacer was not sufficient to elevate VFA concentrations 
enough to cause general changes in histomorphology in the jenunum and crypt elongation 
in the colon. However, numbers of calves were small and further research in this area 
would be useful to validate whether or not psyllium inclusion in milk replacers affects 
gastrointestinal histomorphology.  
Conclusions 
The significant differences in glucose transport observed in this study were 
opposite to predictions and are intriguing. This effect would be expected to indicate a 
cellular level adaptation mediated via systemic effects, and is an area that needs further 
research. Regarding histomorphological measures, inclusion of PSY did not affect 
papillae development in the rumen, villus or crypt size in the small intestine, or crypt 
depth in the colon.  This result also contradicts previous data in other species.  A larger 
dataset, perhaps with higher rates of psyllium inclusion, would be useful to draw a more 
complete conclusion. 
 
  103 
 
References 
Albin, D. M. 2004. Short-chain fatty acids and functional adaptations in the neonatal 
intestine.  Ph.D. Diss., Univ. Illinois, Urbana. 
 
Davis, C. L., and J. K. Drackley. 1998. The Development, Nutrition, and Management of 
the Young Calf. Iowa State University Press, Ames. 
Edwards, C. A., J. Bowen, W. G. Brydon, and M. A. Eastwood. 1992. The effects of 
ispaghula on rat caecal fermentation and stool output. Br. J. Nutr. 68:473-482. 
Edwards, S., M. F. Chaplin, A. D. Blackwood, and P. W. Dettmar. 2003. Primary 
structure of arabinoxylans of ispaghula husk and wheat bran. Proc. Nutr. Soc. 
62:217-222. 
Heinrichs, A. J.  2005.  Rumen development in the dairy calf. Adv. Dairy Tech. 17:179-
187. 
Kles, K. A. and K. A. Tappenden. 2002. Hypoxia differentially regulates nutrient 
transport in rat jejunum regardless of luminal nutrient present. Am. J. Physiol. 
Gastrointest. Liver Physiol. 283:G1336-G1342. 
Kuzmuk, K. N., K. S. Swanson, K. A. Tappenden, L. B. Schook, and G. C. Fahey. 2005.  
Diet and age affect intestinal morphology and large bowel fermentation end-
product concentrations in senior and young adult dogs. J. Nutr. 135: 1940-1945. 
Leng-Peschlow, E. 1991. Plantago ovata seeds as dietary fibre supplement: physiological 
and metabolic effects in rats. Br. J. Nutr. 66:331-349. 
Lesmeister, K. E., P. R. Tozer, and A. J. Heinrichs. 2004. Development and analysis of a 
rumen tissue sampling procedure. J. Dairy Sci. 87:1336-1344. 
Morris, E. R. 2001. Assembly and Rheology of Non-Starch Polysaccharides. In: B. V. 
McCleary and L. Prosky (Eds.) Advanced Dietary Fibre Technology. pp. 30-41. 
Blackwell Science Ltd, Oxford. 
National Animal Health Monitoring System. 2007. Part 1: Reference of Dairy Cattle 
Health and Management Practices in the United States, 2007. Ft. Collins, CO: 
USDA:APHIS:VS:CEAH 
Schneeman, B. O., and D. Richter.  1993.  Changes in plasma and hepatic lipids, small 
intestinal histology and pancreatic enzyme activity due to aging and dietary fiber 
in rats. J. Nutr.  123:1328-1337.  
Sierra, M., J. J. Garcia, N. Fernández, M. J. Diez, A. P. Calle, and Farmafibra Group. 
2002. Therapeutic effects of psyllium in type 2 diabetic patients. Eur. J. Clin. 
Nutr. 56:830-842. 
  104 
 
Tappenden, K. A., D. M. Albin, A. L. Bartholome, and H. F. Mangian. 2003. Glucagon-
like peptide-2 and short-chain fatty acids: a new twist to an old story. J. Nutr. 
133:3717-3720. 
Tamate, H., A. D. McGilliard, N. L. Jacobson, and R. Getty. 1962. Effect of various 
dietaries on the anatomical development of the stomach in the calf. J. Dairy Sci. 
45:408-420. 
 
  i 
 
Table 4.1.  Least squares means and associated standard errors for Isc values (mv) among gastrointestinal tract locations. 
 Week 0   Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 11.55 0.98 3.36
a
 12.82
b
 3.61 7.50 7.34 3.61 13.12 9.18 3.61 9.64 4.96 3.13 6.72 8.58 1.75 0.46 0.39 0.03 
                     
Jejunum 4.06 1.52 3.19 1.57 1.78 0.70 2.22 1.78 3.12 0.94 1.57 3.25 3.82 1.46 2.56 2.13 1.29 0.59 0.26 0.33 
                     
Ileum 1.54 0.57 1.54 0.07 0.95 1.11 0.42 0.95 1.50 0.15 0.95 1.61 1.90 0.95 1.44 0.35 0.48 0.12 0.47 0.68 
                     
Colon 2.42 0.92 0.52 2.73 2.52 5.42 3.66 2.52 1.19 1.24 2.52 5.13 3.69 2.18 3.06 2.83 1.22 0.89 0.38 0.84 
                        
                                             
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week interaction          
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses.  
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b 
Subcolumn means within row and week category with different superscripts differ ( P < 0.01).  
1
0
5
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Table 4.2.  Least squares means and associated standard errors for 
resistance values (R; Ω·cm
2
) among gastrointestinal tract locations. 
 Week 0 Overall diet means  P
1
 
Location Baseline
2
 SE CON PSY SE   T W T*W 
          
Rumen 121.2 8.7 180.6 167.4 16.7  0.58 0.87 0.31 
          
Jejunum 128.7 9.0 103.9 123.5 22.4  0.30 0.84 0.32 
          
Ileum 169.5 18.1 193.2 203.6 12.9  0.50 0.80 0.70 
          
Colon 126.9 1.3 137.0 123.5 7.6  0.18 0.14 0.26 
          
                  
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week 
interaction 
2
 Baseline values are shown for informational purposes and are not included 
in the statistical analyses. 
3 
CON=Control diet 
4 
PSY= Psyllium-supplemented diet 
a,b 
Subcolumn means within row and week category with different 
superscripts differ ( P < 0.01). 
c,d 
Subcolumn means within row and week category with different 
superscripts differ ( P < 0.20). 
1 
1
0
6
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Table 4.3.  Least squares means and associated standard errors of Pdo (mv) values among locations. 
    
 Week 0  Week 1  Week 2  Week 3  Week 4  Overall diet means   P
1
 
Location Baseline
2
 SE   CON
3
 PSY
4
 SE   CON PSY SE   CON PSY SE   CON PSY SE   CON PSY SE   T W T*W 
                           
Rumen 1.38 0.09  -0.28
a
 2.90
b
 0.78  1.46 0.97 0.78  2.07 1.67 0.78  1.82 0.65 0.67  1.27 1.55 0.38  0.60 0.80 0.04 
                           
Jejunum 0.48 0.16  0.33 0.25 0.24  0.13 0.23 0.24  0.32 0.12 0.21  0.53 0.26 0.20  0.33 0.21 0.18  0.29 0.45 0.65 
                           
Ileum 0.25 0.10  0.27 0.01 0.20  0.22 -0.14 0.20  0.31 0.01 0.20  0.31 0.42 0.20  0.28 0.08 0.10  0.17 0.43 0.62 
                           
Colon 0.30 0.11  0.05 0.28 0.28  0.92 0.37 0.28  0.13 0.14 0.28  0.77 0.22 0.24  0.47 0.25 0.14  0.28 0.22 0.40 
                               
                                                  
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction             
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses.     
3 
CON=Control diet             
4 
PSY= Psyllium-supplemented diet             
a,b 
Subcolumn means within row and week category with different superscripts differ ( P  < 0.01).     
2 
1
0
7
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Table 4.4.  gastrointestinal tract locations. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.24 0.15 1.55
a
 0.31
b
 0.34 0.57 0.20 0.34 0.29 0.27 0.34 0.70 0.65 0.32 0.78 0.36 0.28 0.01 0.03 0.03 
                     
Jejunum 0.84 0.41 0.06 0.24 0.32 0.32 0.05 0.32 0.17 0.67 0.26 0.10 0.31 0.22 0.16 0.32 0.14 0.42 0.73 0.59 
                     
Ileum 0.18 0.16 1.01 0.15 0.15 0.64 0.16 0.15 0.64 0.34 0.15 0.24 0.07 0.15 0.63 0.18 0.08 <0.001 0.05 0.15 
                     
Colon 0.26 0.06 1.84
c
 -0.01
d
 0.31 0.54 0.28 0.31 0.31 0.19 0.31 0.61
e
 -0.06
f
 0.27 0.82 0.11 0.16 0.003 0.13 0.04 
                      
                                        
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week interaction      
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b,c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.001). 
e,f 
Subcolumn means within row and week category with different superscripts differ ( P < 0.10). 
1
0
8
 
 
  i 
 
Table 4.5.  gastrointestinal tract locations. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.90 0.64 0.49 0.61 0.46 1.17 0.90 0.46 0.15 1.67 0.46 0.65 0.93 0.41 0.62 1.03 0.27 0.18 0.71 0.22 
                     
Jejunum 0.47 0.23 0.08 0.69 0.38 0.18 0.10 0.38 0.45 0.56 0.31 0.35 0.36 0.28 0.26 0.43 0.21 0.43 0.68 0.67 
                     
Ileum 0.19 0.17 0.55
a
 0.91
b
 0.18 0.64
c
 0.04
d
 0.18 0.36
e
 0.83
f
 0.18 0.38 0.23 0.18 0.48 0.50 0.09 0.87 0.08 0.03 
                     
Colon 0.98 0.33 0.59 0.00 0.34 0.75 0.00 0.34 0.76 0.92 0.34 0.48 0.17 0.29 0.65 0.27 0.16 0.13 0.35 0.57 
                     
                                          
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week interaction        
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet         
4 
PSY= Psyllium-supplemented diet         
a,b 
Subcolumn means within row and week category with different superscripts differ ( P < 0.20). 
c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.05). 
e,f 
Subcolumn means within row and week category with different superscripts differ ( P < 0.10). 
1
0
9
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Table 4.6.  Least squares means and associated standard errors for 
glycylsarcosine transport among gastrointestinal tract locations. 
 Week 0 Overall diet means   P
1
 
Location Baseline
2
 SE CON PSY SE   T W T*W 
          
Rumen 0.13 0.13 0.39 0.36 0.20  0.77 0.04 0.53 
          
Jejunum 0.04 0.02 0.16 0.15 0.05  0.89 0.23 0.57 
          
Ileum 0.11 0.05 0.09 0.05 0.03  0.44 0.63 0.77 
          
Colon 0.12 0.05 0.07 0.07 0.03  0.93 0.70 0.09 
              
                    
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x 
week interaction 
2
 Baseline values are shown for informational purposes and are not 
included in the statistical analyses. 
3 
CON=Control diet 
4 
PSY= Psyllium-supplemented diet 
a,b 
Subcolumn means within row and week category with different 
superscripts differ ( P < 0.05). 
 
Table 4.7.  Least squares means and associated standard errors for 
proline transport among gastrointestinal tract locations. 
 Week 0 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE T W T*W 
         
Rumen 0.13 0.10 0.41 0.34 0.21 0.70 0.09 0.18 
         
Jejunum 0.00 0.00 0.05 0.04 0.02 0.93 0.12 0.18 
         
Ileum 0.00 0.00 0.21 0.05 0.14 0.22 0.46 0.37 
         
Colon 0.00 0.00 0.03 0.16 0.09 0.18 0.43 0.33 
         
                  
1
 P-value.  T= effect of treatment, W=effect of week, 
T*W=treatment x week Interaction  
2
 Baseline values are shown for informational purposes and are not 
included in the statistical analyses. 
3
 CON=Control diet  
4 
PSY=Psyllium-supplemented diet  
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Table 4.8.  Least squares means and associated standard errors for arginine transport among gastrointestinal tract locations.    
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.38 0.28 0.06
a
 0.69
b
 0.23 1.46
c
 0.34
d
 0.23 0.54 0.19 0.23 0.12 0.09 0.21 0.55 0.33 0.15 0.12 0.004 0.003 
                     
Jejunum 0.00 0.00 0.18 0.18 0.07 0.02 0.03 0.07 0.09 0.04 0.06 0.00 0.09 0.05 0.07 0.08 0.04 0.78 0.08 0.50 
                     
Ileum 0.04 0.02 0.01 0.29 0.22 0.61 0.03 0.22 0.71 0.03 0.22 0.03 0.07 0.22 0.34 0.10 0.11 0.13 0.41 0.11 
                     
Colon 0.12 0.04 0.07 1.04 0.27 0.28 0.26 0.27 0.28 0.42 0.27 0.01 0.09 0.24 0.16 0.45 0.14 0.12 0.26 0.25 
                        
                                                
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week interaction            
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses.    
3 
CON=Control diet            
4 
PSY= Psyllium-supplemented diet            
a,b 
Subcolumn means within row and week category with different superscripts differ ( P < 0.05).    
c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.001).    
 
 
 
   
1
1
1
 
 
  i 
 
Table 4.9.  Least squares means and associated standard errors for threonine transport among gastrointestinal tract locations. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.21 0.11 0.040
a
 0.72
b
 0.19 1.14
c
 0.31
d
 0.19 0.20 0.36 0.19 0.37 0.27 0.18 0.44 0.41 0.15 0.82 0.02 <0.001 
                     
Jejunum 0.04 0.03 0.10 0.09 0.12 0.02 0.00 0.12 0.11 0.00 0.10 0.30 0.06 0.09 0.13 0.04 0.05 0.25 0.35 0.62 
                     
Ileum 0.05 0.02 0.16 0.01 0.13 0.38 0.01 0.13 0.03 0.05 0.13 0.04 0.05 0.13 0.03 0.15 0.08 0.15 0.49 0.33 
                     
Colon 0.03 0.01 0.00 0.18 0.08 0.02 0.00 0.08 0.08 -0.01 0.08 0.06 0.01 0.07 0.04 0.04 0.04 0.93 0.73 0.29 
                     
                                          
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x week interaction          
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet          
4 
PSY= Psyllium-supplemented diet          
a,b,c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.01). 
c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.20). 
1
1
2
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Table 4.10.   Least squares means and associated standard errors for papillae length and width (µm) in the rumen   
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Dorsal rumen                   
  Length 469.0 105.0 505.4 459.3 82.0 363.7 379.4 82.0 384.4 325.2 82.0 312.2 386.4 74.0 391.4 387.6 50.9 0.94 0.25 0.75 
  Width 84.0 12.2 78.0 92.2 8.4 98.6 97.2 8.4 95.1 98.3 8.4 84.4 86.2 7.7 89.0 93.5 5.9 0.36 0.12 0.69 
                     
Cranial ventral sac                   
  Length 406.0 71.0 457.8 356.3 83.5 528.0 570.0 83.5 497.2 384.3 83.5 236.8 321.8 75.5 429.9 408.1 56.7 0.65 0.01 0.36 
  Width 60.0 9.1 67.5 66.8 9.4 72.0 82.9 9.4 90.6 81.0 9.4 63.6 82.3 8.3 73.4 78.3 5.6 0.42 0.21 0.34 
                     
Caudal ventral blind sac                
  Length 485.0 189.0 530.7 357.9 58.4 306.4 304.4 58.4 282.3 303.4 68.9 378.0 332.5 52.1 374.3 324.6 37.4 0.21 0.05 0.32 
  Width 66.0 5.9 80.7 74.4 5.5 80.6 74.4 5.5 69.7 83.7 6.7 85.8 90.0 4.8 79.2 80.6 2.8 0.73 0.13 0.32 
                           
                                         
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week Interaction       
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses.  
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet       
1
1
3
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Table 4.11.  Least squares means and associated standard errors for villi height, villi width, and crypt depth (µm) in 
the jejunum 
 Week 0 Overall diet means P
1
 
Measurement Baseline
2
 SE CON
3
 PSY
4
 SE T W T*W 
         
Villi height 560 75 701.7 598.2 58.1 0.21 0.85 0.57 
         
Villi width 99 16 101.9 100.2 9.0 0.84 0.88 0.60 
         
Crypt depth
a
 251 52 249.2 273.7 29.8 0.61 0.21 0.16 
                  
         
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week Interaction  
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3
 CON=Control diet  
4 
PSY=Psyllium-supplemented diet 
 
1
1
4
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Table 4.12.  Least squares means and associated standard errors for crypt width and depth (µm) in the colon 
  
 Week 0 Overall diet means P
1
 
Measurement Baseline
2
 SE CON
2
 PSY
3
 SE T W T*W 
         
Crypt depth 454 32 346.9 312.5 22.0 0.16 0.07 0.99 
         
Crypt width 75 3.9 58.6 56.7 3.9 0.67 0.40 0.49 
                
                  
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction  
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3
 CON=Control diet 
4 
PSY=Psyllium-supplemented diet 
 
1
1
5
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CHAPTER 5 
Conclusions and Implications 
Overall, this trial yielded many intriguing results. The effects of psyllium 
inclusion at 1.1% in neonatal dairy calf milk replacers are potentially beneficial to the 
calf.  With psyllium acting as a viscous, fermentable substrate inside the calf, there were 
several benefits on gastrointestinal growth and development. 
The observation of increased digesta viscosity in the PSY treatment is quite 
logical, as psyllium is a viscous soluble fiber. The increase in digesta viscosity and 
increase in MRT go hand in hand. An area for further research to be done in this area 
would be effects of psyllium supplementation when calf starters are available. It could be 
hypothesized that psyllium inclusion in the milk replacer and calf starter consumption 
could be synergistic. There is the potential for more complete digestion of dietary 
components due to a slower rate of passage. Although there were no significant 
differences in digestibilities in this trial, the trial was not performed in a typical calf 
rearing system with consumption of calf starter, nor was milk replacer offered at a 
biologically normal rate to allow for maximum growth and performance.  
Fermentation of psyllium within the gastrointestinal tract resulted in significantly 
higher concentrations of VFA in the proximal and distal colon, which in turn resulted in 
an increase in size and scale of the gastrointestinal tract.  The increased size and scale of 
the gastrointestinal system of neonatal dairy calves could be of potential benefit to calf 
health from the standpoint of potentially greater absorptive capacities of the tissue, and 
greater tissue resistance to disease intrusion into the blood. Furthermore, inclusion of 
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psyllium as a fermentable substrate could potentially assist in preparing the calf for more 
rapid gastrointestinal growth and development once calf starter consumption begins.  
 The lack of significant microbial changes in the gastrointestinal tract despite the 
increase in VFA could be due to subtle differences or a small sample size with an assay 
with a larger margin of error compared to other assays utilized in this study. This is an 
area that merits further research with a larger sample size to determine potential effects of 
inclusion of psyllium in milk replacers on microbial populations of the gastrointestinal 
system of the neonatal dairy calf. 
One of the more intriguing findings of this study was the significantly higher 
glucose transport rates for the control (non-supplemented) calves, with the CON calves 
exhibiting higher rates of glusose transport in the rumen, ileum, and colon. These data 
agree with the blood glucose data indicating a trend for higher blood glucose 
concentrations pre-prandially for the PSY calves. Therefore, it can be theorized that the 
rate of glucose absorption was slowed with inclusion of psyllium (ion transport data), so 
that glucose was absorbed over a longer period of time (blood glucose data). This theory 
supports the idea of viscosity slowing the rate of absorption, but contradicts research 
performed in other monogastric species in which elevated rates of glucose absorption 
were noted as a result of increased VFA absorption. However, this data set does suggest 
that there is some sort of systemic effect of psyllium inclusion, as the glucose rates 
were lower in the rumens of calves fed PSYdespite the esophageal groove shunting milk 
replacer past the rumen. Furthermore, there was a tendency for the PSY rumens to be 
larger; also indicative of the presence of some sort of systemic feedback mechanism.  
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Overall, this trial yielded strong data in support of potential benefit to psyllium 
supplementation in milk replacers but also indicates the need for further research in the 
area. Regarding the microbial results and the histomorphology data, a much larger data 
set would be advantageous due to the larger margin of error with those two laboratory 
assays . In order to evaluate psyllium’s effectiveness in a “real-world” application, a 
study must be done with calf starter inclusion and milk replacers fed at a more 
biologically appropriate level with much larger numbers of calves. Most importantly, in 
order for psyllium to be used on farm, it must be cost-effective and provide a decent 
return on the investment for today’s modern progressive dairy producers to utilize this 
technology.  
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APPENDIX 
Appendix 1. Least squares means and associated standard errors for water, dry matter, and nutrient intakes. 
 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Intake CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                   
Morning, L 1.04 1.18 0.3 2.12 2.24 0.33 3.23 3.84 0.38 2.22 1.36 0.5 2.15 2.16 0.19 0.99 <.0001 0.44 
                   
Night, L 0.9 1.14 0.29 1.2 1.06 0.32 1.48 2.56 0.36 1.26 1.59 0.5 1.21 1.58 0.21 0.12 0.01 0.3 
                   
Daily, L 1.81 1.94 0.52 3.29 3.27 0.57 4.7 6.39 0.65 3.48 2.31 0.9 3.32 3.47 0.33 0.75 <.0001 0.28 
                   
DMI, g/d 669 686 26.3 685 697 28.5 719 752 32.3 776 791 40.1 712 732 21.7 0.31 0.001 0.98 
                   
Protein, g/d 146 148 5.7 149 151 5.7 157 162 7.0 169 171 8.7 155 158 4.7 0.50 0.013 0.98 
                   
ME, kcal/d 2915 2978 115 2988 3025 124 3135 3262 140 3384 3434 174 3175 3105 95 0.39 0.013 0.98 
                   
                                      
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction    
2 
CON = Control diet    
3 
PSY = Psyllium-supplemented diet    
1
1
9
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Appendix 2. Least squares means and associated standard errors for average daily growth. 
 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                   
Body length, cm/d 0.10 0.00 0.07 0.39
a
 0.05
b
 0.08 0.15 0.27 0.10 0.16 0.14 0.12 0.20 0.12 0.05 0.17 0.08 0.04 
                   
Heart girth, cm/d 0.29 0.27 0.07 0.15 0.16 0.07 0.34 0.26 0.08 0.00 0.00 0.11 0.19 0.17 0.04 0.76 0.01 0.94 
                   
Withers height, cm/d 0.24 0.20 0.07 0.26 0.14 0.08 0.21 0.28 0.10 0.16 0.15 0.13 0.22 0.19 0.05 0.71 0.85 0.69 
                   
Body weight, kg/d 0.10 0.12 0.05 0.29 0.24 0.06 0.45 0.47 0.07 0.25 0.33 0.09 0.29 0.27 0.04 0.66 <.001 0.82 
                   
Predicted BW gain
4
, kg/d 0.51 0.52  0.52 0.52  0.54 0.55  0.59 0.60  0.54 0.55     
                   
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction      
2 
CON = Control diet    
3 
PSY = Psyllium-supplemented diet    
a,b
 Subcolumn means within row and week category with different superscripts differ (P < 0.05).   
4 
Predicted average daily gain according to NRC (2001). Not analyzed statistically, but shown for information purposes.   
1
2
0
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Appendix 3. Least squares means and associated standard errors for viscosity of digesta. 
            
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
1
 SE CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 13.28 1.45 7.78 8.28 1.02 7.3 8.28 1.02 10.37 9.21 1.02 15.22 9.44 0.88 10.17 8.80 0.98 0.33 0.08 0.25 
                    
Abomasum . . 19.6 31.01 4.46 21.86 45.54 5.17 16.9 35.01 4.46 14.02 24.89 4.46 18.10 34.11 6.88 0.004 0.28 0.77 
                    
Jejunum
4
 477.29 197.98 19.37 16.34 3.39 21.03 24.69 3.39 15.58 18.38 3.39 29.79 20.21 3.12 21.44 19.91 4.81 0.69 0.36 0.54 
                    
Colon
4
 4.49 0.2 3.93 4.99 0.14 4.16 4.6 0.14 3.27 4.66 0.14 3.31 4.7 0.12 3.67 4.74 0.14 <0.001 0.16 0.24 
                      
                                            
1
 Baseline values are shown for comparison purposes and are not included in the statistical analyses.       
2 
CON=Control Treatment.       
3 
PSY= Psyllium Treatment       
4
 Data were Log
10
 transformed for statistical analysis, but back-transformed means are shown for ease of interpretation.       
1
2
1
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 Appendix 4.  Least squares means and associated standard errors for viscosity of digesta. 
            
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
1
 SE CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 13.28 1.45 7.78 8.28 1.02 7.3 8.28 1.02 10.37 9.21 1.02 15.22 9.44 0.88 10.17 8.80 0.98 0.33 0.08 0.25 
                    
Abomasum . . 19.6 31.01 4.46 21.86 45.54 5.17 16.9 35.01 4.46 14.02 24.89 4.46 18.10 34.11 6.88 0.004 0.28 0.77 
                    
Jejunum
4
 477.29 197.98 19.37 16.34 3.39 21.03 24.69 3.39 15.58 18.38 3.39 29.79 20.21 3.12 21.44 19.91 4.81 0.69 0.36 0.54 
                    
Colon
4
 4.49 0.2 3.93 4.99 0.14 4.16 4.6 0.14 3.27 4.66 0.14 3.31 4.7 0.12 3.67 4.74 0.14 <0.001 0.16 0.24 
                      
                                            
1
 Baseline values are shown for comparison purposes and are not included in the statistical analyses.       
2 
CON=Control Treatment.       
3 
PSY= Psyllium Treatment       
4
 Data were Log
10
 transformed for statistical analysis, but back-transformed means are shown for ease of interpretation.       
 
1
2
2
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Appendix 5. Least squares means and associated standard errors for mean digesta retention time in the total tract. 
 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location CON
2
 PSY
3
 SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                      
Mean 
retention 
time, h 8.35 9.46 0.47 8.26 10.24 0.47 8.73 9.42 0.47 8.45 9.71 0.59 0.106 0.93 0.76 
                    
                              
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction 
2 
CON=Control Treatment. 
3 
PSY= Psyllium Treatment      
      
1
2
3
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Appendix 6. Least squares means and associated standard errors for weekly dry matter contents (%) of gastrointestinal tract digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                        
Rumen 2.4 0 1.7 1.3 0.00 1.2 2.2 0.00 1.4 1.2 0.00 2 2.3 0.00 1.5 1.7 0.00 0.52 0.18 0.32 
                     
Abomasum 38.4 0.06 2.9 2.2 0.02 2.5 2.6 0.02 3.3 2.9 0.02 6.3 3 0.01 3.8 2.7 0.01 0.28 0.3 0.52 
                     
Jejunum 5 0 9.5 7.3 0.01 8.3 8.1 0.01 6.9 6.2 0.01 8 8.9 0.01 8.2 7.6 0.01 0.55 0.38 0.62 
                     
Proximal 
colon 22.2 0.04 16.1 14.7 0.02 18 13.4 0.02 18.2 14.9 0.02 16.7 12.2 0.02 17.3 13.8 0.01 0.017 0.74 0.84 
                     
Distal colon 29.1 0.06 20.1 19.5 0.02 21.5 15.9 0.02 23.4 21.1 0.03 18.8 14.8 0.02 20.9 17.8 0.01 0.05 0.1 0.65 
                     
                                          
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for comparison purposes and are not included in the statistical analyses.   
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet       
  
1
2
4
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Appendix 7. Least squares means and associated standard errors for weekly dry matter contents (%) of gastrointestinal tract digesta. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                        
Rumen 2.4 0 1.7 1.3 0.00 1.2 2.2 0.00 1.4 1.2 0.00 2 2.3 0.00 1.5 1.7 0.00 0.52 0.18 0.32 
                     
Abo-masum 38.4 0.06 2.9 2.2 0.02 2.5 2.6 0.02 3.3 2.9 0.02 6.3 3 0.01 3.8 2.7 0.01 0.28 0.3 0.52 
                     
Jejunum 5 0 9.5 7.3 0.01 8.3 8.1 0.01 6.9 6.2 0.01 8 8.9 0.01 8.2 7.6 0.01 0.55 0.38 0.62 
                     
Proximal 
colon 22.2 0.04 16.1 14.7 0.02 18 13.4 0.02 18.2 14.9 0.02 16.7 12.2 0.02 17.3 13.8 0.01 0.017 0.74 0.84 
                     
Distal colon 29.1 0.06 20.1 19.5 0.02 21.5 15.9 0.02 23.4 21.1 0.03 18.8 14.8 0.02 20.9 17.8 0.01 0.05 0.1 0.65 
                     
                                          
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for comparison purposes and are not included in the statistical analyses.   
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet       
  
 
1
2
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Appendix 8.  Least squares means and associated standard errors for weekly pre-prandial blood constituents. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
Glucose, 
mg/dL 102.6 3.2 95.9 98.0 4.6 94.5 99.3 4.8 96.5 97.8 5.2 91.2 101.6 6 94.6 99.2 4.2 0.064 1.00 0.67 
                     
NEFA 395 29.5 282 264 26.8 263 220 30.2 198 175 33 231 265 41.2 244 231 22 0.52 0.011 0.66 
                     
BHBA, 
mmol/L 0.06 0.01 0.05 0.04 0.01 0.05 0.05 0.02 0.06 0.05 0.02 0.1 0.1 0.02 0.06 0.06 0.01 0.80 0.081 0.96 
                     
Cholest-   
erol, mg/dL 27.9 1.6 59 51 3.6 69.3 66.7 4.00 76.6 85.8 4.7 95.2 83.1 6.14 75.1 71.6 2.5 0.28 <.001 0.123 
                     
Urea N, 
mg/dL 12.6 0.94 6.1 6.0 0.66 6.4 5.5 0.71 6.4 6.0 0.80 6.3 6.9 1.0 6.3 6.1 0.54 0.68 0.85 0.81 
                     
Total 
protein, 
mg/dL 5.77 0.11 5.92 5.67 0.26 5.94 5.59 0.27 5.63 5.65 0.29 5.43 5.48 0.34 5.73 5.6 0.23 0.36 0.40 0.69 
                                          
 
        
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses.       
3 
CON=Control diet      
4 
PSY= Psyllium-supplemented diet      
  
 
 
 
 
 
1
2
6
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Appendix 9.  Least squares means and associated standard errors for weekly post-prandial blood constituents. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
Glucose, 
mg/dL 103.59 4.23 110.9 109.5 4.1 101 104.2 4.6 96.3 100.8 5.5 101.5 107.8 7.2 102.5 105.7 2.8 0.42 0.073 0.87 
                     
NEFA 261 22.4 212 238 17.3 179 178 19.4 192 168 22.3 180 158 29.7 191 185 12.6 0.73 0.013 0.52 
                     
BHBA, 
mmol/L 0.05 0.01 0.0 0.0 0.01 0.0 0.0 0.01 0 0 0.01 0.03 0.04 0.01 0.02 0.02 0.01 0.45 <0.001 0.74 
                     
Cholesterol, 
mg/dL 26.4 1.3 53.9 51.3 4.5 66 66.9 4.9 67 79.2 5.6 84 73 7.1 67.9 68.1 3 0.96 <0.001 0.18 
                     
Urea N, 
mg/dL 12 0.98 5.9 6.1 0.72 6.5 5.7 0.74 5.9 5.6 0.79 6.2 5.9 0.91 6.2 5.8 0.73 0.44 0.89 0.64 
                     
Total 
protein, 
mg/dL 5.1 0.43 5.3 5.2 0.6 5.44 5.43 0.61 4.9 5.17 0.62 4.8 4.64 0.65 5.13 5.1 0.61 0.99 0.018 0.76 
                       
                                        
1
 P-value.  T = effect of treatment, W = effect of week, T*W = treatment x week interaction       
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet       
  
 
1
2
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Appendix 10.  Least squares means and associated standard errors of weekly duodenal (DU) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, cm 27.5 2.4 25.7 28.0 4.4 40.3 32.7 4.4 29.7 31.0 4.4 25.3 30.8 3.8 30.2 30.6 2.1 0.89 0.15 0.45 
                     
Weight, g 50.6 4.0 49.9 68.1 11.3 51.3 65.6 11.3 53.9 63.7 11.3 51.2 64.2 10.9 50.6 67.9 8.2 0.03 0.83 0.83 
                     
g DU per kg 
BW 0.98 0.04 1.12 1.49 0.23 1.09 1.47 0.23 1.06 1.17 0.23 0.94 1.41 0.21 1.05 1.38 0.16 0.02 0.73 0.78 
                     
Density 
(g/cm) 1.94 0.05 1.92 2.41 0.39 1.42 1.99 0.39 1.82 2.02 0.39 2.05 2.48 0.35 1.80 2.22 0.28 0.06 0.25 0.94 
                     
Cm DU per 
kg BW 0.56 0.04 0.60 0.61 0.10 0.89 0.75 0.10 0.60 0.59 0.10 0.47 0.57 0.09 0.64 0.63 0.05 0.86 0.03 0.64 
                     
(g/cm)/ kg 
BW 0.04 0.00 0.04 0.05 0.01 0.03 0.05 0.01 0.04 0.04 0.01 0.04 0.05 0.01 0.04 0.05 0.01 0.06 0.27 0.74 
                                      
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction      
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet.   
4 
PSY= Psyllium-supplemented diet.   
1
2
8
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Appendix 11.  Least squares means and associated standard errors of weekly ileum (IE) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, 
cm 94.9 38.5 79.7 88.3 24.6 36.7 50.3 24.6 61.7 64.7 24.6 57.8 77.0 21.3 58.9 70.1 11.9 0.51 0.45 0.99 
                     
Weight, 
g 124.2 68.3 66.8 45.5 19.4 28.0 61.7 19.4 60.3 91.9 19.4 54.8 71.0 16.8 52.5 67.5 9.4 0.27 0.46 0.48 
                     
g IE per 
kg BW 2.42 1.26 1.61 1.03 0.44 0.62 1.40 0.44 1.21 1.82 0.44 1.04 1.32 0.38 1.12 1.39 0.21 0.37 0.70 0.43 
                     
Density 
(g/cm) 1.22 0.21 0.80 0.80 0.19 0.80 1.26 0.19 1.09 1.40 0.19 0.99 1.02 0.17 0.92 1.12 0.12 0.08 0.09 0.40 
                     
Cm IE 
per kg 
BW 1.85 0.67 1.87 2.05 0.57 0.80 1.15 0.57 1.25 1.27 0.57 1.11 1.41 0.50 1.26 1.47 0.28 0.59 0.38 0.99 
                     
(g/cm)/ 
kg BW 0.02 0.00 0.02 0.02 0.00 0.02 0.03 0.00 0.02 0.03 0.00 0.02 0.02 0.00 0.02 0.02 0.00 0.15 0.23 0.30 
                                        
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction      
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet      
4 
PSY= Psyllium-supplemented diet      
1
2
9
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Appendix 12.  Least squares means and associated standard errors of weekly colon (COL) growth parameters. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Variable Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Length, 
cm 215.2 25.3 217.6 192.5 18.7 175.0 163.6 18.7 175.7 189.5 18.7 196.8 190.7 16.9 191.3 184.1 12.6 0.51 0.16 0.67 
                     
Weight, 
g 369.0 19.3 416.5 424.8 38.5 416.5 470.0 38.5 389.9 517.5 38.5 408.6 457.0 33.3 407.9 467.3 18.6 0.04 0.84 0.49 
                     
g COL 
per kg 
BW 7.51 0.29 9.36 9.17 0.65 8.97 10.72 0.65 7.76 9.60 0.65 7.63 8.31 0.59 8.43 9.45 0.45 0.01 0.01 0.21 
                     
Density 
(g/cm) 1.78 0.10 2.01 2.19 0.32 2.42 2.91 0.32 2.24 2.76 0.32 2.09 2.45 0.29 2.19 2.58 0.21 0.06 0.21 0.93 
                     
Cm 
COL 
per kg 
BW 4.28 0.26 4.95 4.17 0.43 3.82 3.73 0.43 3.49 3.52 0.43 3.67 3.53 0.37 3.98 3.74 0.22 0.41 0.08 0.77 
                     
(g/cm)/ 
kg BW 0.04 0.00 0.05 0.05 0.01 0.05 0.07 0.01 0.05 0.05 0.01 0.04 0.04 0.01 0.05 0.05 0.00 0.04 0.01 0.61 
                                        
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction      
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet      
4 
PSY= Psyllium-supplemented diet      
1
3
0
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Appendix 13.  Least squares means and associated standard errors for resistance values (R; Ω·cm
2
) among gastrointestinal tract locations. 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location 
Base-
line
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 121.2 8.7 170.7 212.0 34.5 208.8 131.4 34.5 156.4 178.9 34.5 186.6 147.3 29.9 180.6 167.4 16.7 0.58 0.87 0.31 
                     
Jejunum 128.7 9.0 101.8 150.3 36.0 98.7 113.8 36.0 83.0 127.8 30.3 132.3 102.3 27.5 103.9 123.5 22.4 0.30 0.84 0.32 
                     
Ileum 169.5 
18.
1 185.7 204.3 22.1 207.1 215.6 22.1 197.6 181.6 22.1 182.3 213.0 22.1 193.2 203.6 12.9 0.50 0.80 0.70 
                     
Colon 126.9 1.3 117.1 125.3 14.0 161.5 116.3 14.0 116.4 115.9 14.0 153.1 136.5 12.2 137.0 123.5 7.6 0.18 0.14 0.26 
                     
                                      
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet.        
4 
PSY= Psyllium-supplemented diet        
a,b 
Subcolumn means within row and week category with different superscripts differ ( P < 0.01). 
c,d 
Subcolumn means within row and week category with different superscripts differ ( P < 0.20). 
 
1
3
1
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Appendix 14.  Least squares means and associated standard errors for glycylsarcosine transport among gastrointestinal tract locations 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.13 0.13 0.22 0.24 0.25 0.85 0.57 0.25 0.18 0.41 0.25 0.32 0.22 0.23 0.39 0.36 0.20 0.77 0.04 0.53 
                     
Jejunum 0.04 0.02 0.17 0.22 0.10 0.00 0.08 0.10 0.30 0.15 0.08 0.16 0.15 0.07 0.16 0.15 0.05 0.89 0.23 0.57 
                     
Ileum 0.11 0.05 0.13 0.11 0.06 0.09 0.00 0.06 0.05 0.08 0.06 0.09 0.02 0.06 0.09 0.05 0.03 0.44 0.63 0.77 
                     
Colon 0.12 0.05 0.13 0.03 0.06 0.07 0.00 0.06 0.001
a
 0.208
b
 0.06 0.06 0.04 0.05 0.07 0.07 0.03 0.93 0.70 0.09 
                        
                                       
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet     
4 
PSY= Psyllium-supplemented diet      
a,b 
Subcolumn means within row and week category with different superscripts differ ( P < 0.05). 
1
3
2
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Appendix 15.  Least squares means and associated standard errors for proline transport among gastrointestinal tract locations 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Rumen 0.13 0.10 0.08 0.28 0.30 1.14 0.42 0.30 0.14 0.52 0.30 0.27 0.16 0.28 0.41 0.34 0.21 0.70 0.09 0.18 
                     
Jejunum 0.00 0.00 0.00 0.01 0.04 0.05 0.00 0.04 0.09 0.04 0.03 0.04 0.12 0.03 0.05 0.04 0.02 0.93 0.12 0.18 
                     
Ileum 0.00 0.00 0.20 0.06 0.21 0.56 0.03 0.21 0.03 0.07 0.21 0.05 0.04 0.21 0.21 0.05 0.14 0.22 0.46 0.37 
                     
Colon 0.00 0.00 0.05 0.02 0.14 0.06 0.08 0.14 0.02 0.43 0.14 0.00 0.10 0.13 0.03 0.16 0.09 0.18 0.43 0.33 
                        
                                       
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction       
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet       
1
3
3
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Appendix 16.  Least squares means and associated standard errors for villi height, villi width, and crypt depth (µm) in the jejunum 
 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Villi 
height 560 75 695 592 113 567 656 138 734 552 113 811 592 98 702 598 58 0.21 0.85 0.57 
                     
Villi 
width 99 16 112 101 13 92 108 13 107 92 13 97 99 12 102 100 9 0.84 0.88 0.60 
                     
Crypt 
Depth
a
 251 52 253 192 35 253 305 40 307 250 35 307 250 35 249 274 30 0.61 0.21 0.16 
                           
                                         
1
 P-value.  T= effect of treatment, W=effect of week, T*W=treatment x week Interaction 
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3
 CON=Control diet              
4 
PSY=Psyllium-supplemented diet             
1
3
4
 
 
  i 
 
Appendix 17.  Least squares means and associated standard errors for crypt width and depth (µm) in the colon 
 
 Week 0 Week 1 Week 2 Week 3 Week 4 Overall diet means P
1
 
Location Baseline
2
 SE CON
3
 PSY
4
 SE CON PSY SE CON PSY SE CON PSY SE CON PSY SE T W T*W 
                     
Crypt 
depth
a
 454 32 396 358 38 360 335 38 305 275 38 326 282 33 347 312.5 22.0 0.16 0.07 0.99 
                     
Crypt 
width 75 4 61 65 7 57 64 7 59 50 7 58 49 6 59 56.7 3.9 0.67 0.40 0.49 
                        
                      
1
 P-value.  T= effect of treatment, W=effect of week, T*W=Treatment x Week Interaction         
2
 Baseline values are shown for informational purposes and are not included in the statistical analyses. 
3 
CON=Control diet       
4 
PSY= Psyllium-supplemented diet        
 
1
3
5
 
 
